Document:

EX-10.2

 Exhibit 10.2 

Execution Version 

COMMON UNIT PURCHASE AGREEMENT 

by and among 
 CRESTWOOD
GAS SERVICES HOLDINGS LLC, 
 THE PURCHASERS NAMED ON SCHEDULE A HERETO 

and 
 CRESTWOOD EQUITY
PARTNERS LP 
  

 TABLE OF CONTENTS 

 

							
	 ARTICLE I DEFINITIONS
	  	 	4	 
			
	 Section 1.1
	 	Definitions	  	 	4	 
		
	 ARTICLE II AGREEMENT TO SELL AND PURCHASE
	  	 	7	 
	 Section 2.1
	 	Sale and Purchase	  	 	7	 
	 Section 2.2
	 	Closing	  	 	7	 
	 Section 2.3
	 	Mutual Conditions	  	 	8	 
	 Section 2.4
	 	Each Purchaser’s Conditions	  	 	8	 
	 Section 2.5
	 	Seller’s Conditions	  	 	9	 
	 Section 2.6
	 	Seller Deliveries	  	 	9	 
	 Section 2.7
	 	Purchaser Deliveries	  	 	9	 
	 Section 2.8
	 	Partnership Deliveries	  	 	10	 
	 Section 2.9
	 	Independent Nature of Purchasers’ Obligations and Rights	  	 	10	 
		
	 ARTICLE III REPRESENTATIONS AND WARRANTIES OF THE SELLER
	  	 	11	 
			
	 Section 3.1
	 	Existence	  	 	11	 
	 Section 3.2
	 	Authorization, Enforceability	  	 	11	 
	 Section 3.3
	 	Common Unit Ownership	  	 	11	 
	 Section 3.4
	 	No Conflicts	  	 	12	 
	 Section 3.5
	 	No Consents	  	 	12	 
	 Section 3.6
	 	No Preemptive Rights	  	 	12	 
	 Section 3.7
	 	Listing	  	 	12	 
	 Section 3.8
	 	Legal Proceedings	  	 	12	 
	 Section 3.9
	 	Certain Fees	  	 	13	 
	 Section 3.10
	 	No Side Agreements	  	 	13	 
	 Section 3.11
	 	No Registration	  	 	13	 
		
	 ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS
	  	 	13	 
			
	 Section 4.1
	 	Existence	  	 	13	 
	 Section 4.2
	 	Authorization, Enforceability	  	 	13	 
	 Section 4.3
	 	No Breach	  	 	13	 
	 Section 4.4
	 	Certain Fees	  	 	14	 
	 Section 4.5
	 	No Side Agreements	  	 	14	 
	 Section 4.6
	 	Investment	  	 	14	 
	 Section 4.7
	 	Nature of Purchaser	  	 	14	 
	 Section 4.8
	 	Restricted Securities	  	 	15	 
	 Section 4.9
	 	Legend	  	 	15	 
	 Section 4.10
	 	Partnership Information	  	 	15	 
	 Section 4.11
	 	Placement Agent Representations	  	 	15	 
	 Section 4.12
	 	Short Selling	  	 	17	 

  
 i 

							
	 ARTICLE V REPRESENTATIONS AND WARRANTIES OF THE PARTNERSHIP
	  	 	17	 
			
	 Section 5.1
	 	Existence	  	 	17	 
	 Section 5.2
	 	Authorization, Enforceability	  	 	18	 
	 Section 5.3
	 	No Conflicts	  	 	18	 
	 Section 5.4
	 	No Consents	  	 	18	 
	 Section 5.5
	 	Duly Authorized and Validly Issued Units	  	 	18	 
	 Section 5.6
	 	Listing	  	 	19	 
	 Section 5.7
	 	Legal Proceedings	  	 	19	 
	 Section 5.8
	 	No Defaults	  	 	19	 
	 Section 5.9
	 	No Registration Rights	  	 	19	 
	 Section 5.10
	 	Periodic Reports	  	 	20	 
	 Section 5.11
	 	Financial Statements	  	 	20	 
	 Section 5.12
	 	No Material Changes	  	 	20	 
	 Section 5.13
	 	Investment Company	  	 	20	 
	 Section 5.14
	 	No Unlawful Payments	  	 	20	 
	 Section 5.15
	 	Compliance with Money Laundering Laws	  	 	21	 
	 Section 5.16
	 	OFAC	  	 	21	 
		
	 ARTICLE VI COVENANTS
	  	 	21	 
			
	 Section 6.1
	 	Taking of Necessary Action	  	 	21	 
	 Section 6.2
	 	Registration Rights Agreement	  	 	22	 
	 Section 6.3
	 	Lock-Up	  	 	22	 
	 Section 6.4
	 	Non-Public Information	  	 	22	 
	 Section 6.5
	 	Use of Proceeds	  	 	23	 
		
	 ARTICLE VII INDEMNIFICATION
	  	 	23	 
			
	 Section 7.1
	 	Indemnification by Seller	  	 	23	 
	 Section 7.2
	 	Indemnification by the Partnership	  	 	23	 
	 Section 7.3
	 	Indemnification by Purchasers	  	 	24	 
	 Section 7.4
	 	Indemnification Procedure	  	 	24	 
		
	 ARTICLE VIII MISCELLANEOUS
	  	 	25	 
			
	 Section 8.1
	 	Interpretation	  	 	25	 
	 Section 8.2
	 	Survival of Provisions	  	 	25	 
	 Section 8.3
	 	No Waiver; Modifications in Writing	  	 	26	 
	 Section 8.4
	 	Binding Effect; Assignment	  	 	26	 
	 Section 8.5
	 	Confidentiality	  	 	26	 
	 Section 8.6
	 	Communications	  	 	26	 
	 Section 8.7
	 	Removal of Legend	  	 	27	 
	 Section 8.8
	 	Most Favored Nation	  	 	28	 
	 Section 8.9
	 	Entire Agreement	  	 	28	 
	 Section 8.10
	 	Expenses	  	 	28	 
	 Section 8.11
	 	Acknowledgement	  	 	28	 

  
 ii 

							
	 Section 8.12
	 	Governing Law	  	 	28	 
	 Section 8.13
	 	Execution in Counterparts	  	 	29	 
	 Section 8.14
	 	Termination	  	 	29	 

  

					
	Schedule A	 	—	 	List of Purchasers and Purchased Units
	Exhibit A	 	—	 	Form of Opinion of Simpson Thacher & Bartlett LLP
	Exhibit B	 	—	 	Form of Registration Rights Agreement

  

  
 iii 

 COMMON UNIT PURCHASE AGREEMENT 

This COMMON UNIT PURCHASE AGREEMENT, dated as of March 25, 2021 (this “Agreement”), is by and among Crestwood Gas
Services Holdings LLC, a Delaware limited liability company (“Seller”), each of the purchasers listed on Schedule A hereof (each a “Purchaser” and collectively, the “Purchasers”), and
Crestwood Equity Partners LP, a Delaware limited partnership (the “Partnership”). 
 WHEREAS, Seller desires to sell to the
Purchasers, and the Purchasers desire to purchase from Seller, certain Common Units representing limited partnership interests (“Common Units”) in the Partnership, in accordance with the provisions of this Agreement. 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt
and sufficiency of which is hereby acknowledged, the Seller and each of the Purchasers, severally and not jointly, hereby agree as follows: 

ARTICLE I 

DEFINITIONS 

Section 1.1 Definitions. As used in this Agreement, and unless the context requires a different meaning, the following terms have
the meanings indicated: 
 “Affiliate” means, with respect to any Person, any other Person that directly or indirectly
through one or more intermediaries controls, is controlled by or is under common control with, the Person in question. As used herein, the term “control” means the possession, direct or indirect, of the power to direct or cause the
direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise. 

“Agreement” has the meaning specified in the introductory paragraph. 

“Business Day” means a day other than (a) a Saturday or Sunday or (b) any day on which banks located in New York,
New York, U.S.A. are authorized or obligated to close. 
 “Closing” has the meaning specified in
Section 2.2. 
 “Closing Date” has the meaning specified in
Section 2.2. 
 “Credit Agreement” means the Credit Agreement, dated as of March 5, 2018,
among Crestwood Holdings LLC, as the borrower, the lenders party thereto from time to time and Morgan Stanley Senior Funding, Inc., as administrative agent and as collateral agent. 

“Code” means the U.S. Internal Revenue Code of 1986, as amended and in effect from time to time. Any reference herein to a
specific section or sections of the Code shall be deemed to include a reference to any corresponding provision of any successor law. 

“Commission” means the United States Securities and Exchange Commission. 

  
 4 

 “Common Unit Price” has the meaning specified in
Section 2.1(b). 
 “Common Units” has the meaning specified in the recitals. 

“Consent” has the meaning specified in Section 3.5. 

“Delaware LP Act” means the Delaware Revised Uniform Limited Partnership Act. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations of the
Commission promulgated thereunder. 
 “Excluded Information” has the meaning specified in
Section 4.11(d) 
 “FINRA” means the Financial Industry Regulatory Authority, Inc. 

“Governmental Authority” means, with respect to a particular Person, any country, state, county, city and political
subdivision in which such Person or such Person’s property is located or that exercises valid jurisdiction over any such Person or such Person’s property, and any court, agency, department, commission, board, bureau or instrumentality of
any of them and any monetary authority that exercises valid jurisdiction over any such Person or such Person’s property. 
 “GP
Transaction Agreement” has the meaning specified in Section 2.3(c). 
 “Law” means any
federal, state, local or foreign order, writ, injunction, judgment, settlement, award, decree, statute, law, rule or regulation. 

“Lien” means any interest in property securing an obligation owed to, or a claim by, a Person other than the owner of the
property, whether such interest is based on the common law, statute or contract, and whether such obligation or claim is fixed or contingent, and including the lien or security interest arising from a mortgage, encumbrance, pledge, security
agreement, conditional sale or trust receipt or a lease, consignment or bailment for security purposes. For the purpose of this Agreement, a Person shall be deemed to be the owner of any property that it has acquired or holds subject to a
conditional sale agreement, or leases under a financing lease or other arrangement pursuant to which title to the property has been retained by or vested in some other Person in a transaction intended to create a financing. 

“Material Adverse Effect” has the meaning specified in Section 5.1. 

“NYSE” means The New York Stock Exchange, Inc. 

“Operative Documents” means, collectively, this Agreement and the Registration Rights Agreement, and any amendments,
supplements, continuations or modifications thereto. 
 “Organizational Documents” means, with respect to any Person, the
certificate of limited partnership, formation or incorporation, agreement of limited partnership, limited liability company agreement, bylaws or any other organizational documents, as applicable to such Person. 

“Partnership” has the meaning specified in the introductory paragraph. 

  
 5 

 “Partnership Agreement” means the Fifth Amended and Restated Agreement of
Limited Partnership of the Partnership, dated April 11, 2014, as amended to date. 
 “Person” means an individual or a
corporation, limited liability company, partnership, joint venture, trust, unincorporated organization, association, government agency or political subdivision thereof or other form of entity. 

“Placement Agent Engagement Letter” means that certain Placement Agent Engagement Letter, dated as of March 25, 2021,
among the Seller, the Partnership and the Placement Agents. 
 “Placement Agents” means Citigroup Global Markets, Inc. and
its Affiliates. 
 “Press Release” has the meaning specified in Section 6.4. 

“Purchase Price” means, with respect to each Purchaser, the dollar amount set forth opposite such Purchaser’s name in
the column titled “Commitment Amount” set forth on Schedule A hereto; provided that in no event shall the Purchase Price applicable to such Purchaser be increased without the prior written consent of such Purchaser. 

“Purchased Units” means the 6,000,000 Common Units to be sold hereunder, and with respect to a particular Purchaser, the
number of Common Units as set forth opposite such Purchaser’s name under the column titled “Purchased Units” set forth on Schedule A. 

“Purchaser” and “Purchasers” have the meanings specified in the introductory paragraph. 

“Purchaser Related Parties” has the meaning specified in Section 7.1. 

“Registration Rights Agreement” means the Registration Rights Agreement substantially in the form attached to this Agreement
as Exhibit B. 
 “Representatives” of any Person means the Affiliates, officers, directors, managers, employees, agents,
counsel, accountants, investment bankers and other representatives of such Person. 
 “SEC Reports” means reports and
statements filed by the Partnership under the Exchange Act and statements filed by the Partnership under the Securities Act (in the form that became effective), including all amendments, exhibits and schedules thereto. 

“Securities Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations of the
Commission promulgated thereunder. 
 “Short Sales” means, without limitation, all “short sales” as defined in
Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and forward sale contracts, options, puts, calls, short sales, “put equivalent positions” (as defined in Rule
16a-1(h) under the Exchange Act) and similar arrangements, and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers. 

  
 6 

 “Subsidiaries” means, with respect to any Person, (a) a corporation of
which more than 50% of the voting power of shares entitled (without regard to the occurrence of any contingency) to vote in the election of directors or other governing body of such corporation is owned, directly or indirectly, at the date of
determination, by such Person, by one or more Subsidiaries of such Person or a combination thereof, (b) a partnership (whether general or limited) in which such Person or a Subsidiary of such Person is, at the date of determination, a general
or limited partner of such partnership, but only if more than 50% of the partnership interests of such partnership (considering all of the partnership interests of the partnership as a single class) is owned, directly or indirectly, at the date of
determination, by such Person, by one or more Subsidiaries of such Person, or a combination thereof, or (c) any other Person (other than a corporation or a partnership) in which such Person, one or more Subsidiaries of such Person, or a
combination thereof, directly or indirectly, at the date of determination, has (i) at least a majority ownership interest or (ii) the power to elect or direct the election of a majority of the directors or other governing body of such
Person. 
 “Walled Off Person” has the meaning specified in Section 4.12. 

ARTICLE II 

AGREEMENT TO SELL AND PURCHASE 

Section 2.1 Sale and Purchase. 

(a) Subject to the terms and conditions hereof, Seller hereby agrees to sell to each Purchaser and each Purchaser hereby agrees, severally and
not jointly, to purchase from Seller its respective Purchased Units, and each Purchaser agrees, severally and not jointly, to pay Seller the Common Unit Price for each Purchased Unit as set forth in Section 2.1(b) below.

 (b) The amount per Common Unit each Purchaser will pay to Seller to purchase the Purchased Units hereunder shall be $22.00 (the
“Common Unit Price”). 
 Section 2.2 Closing. Subject to the terms and conditions hereof, the consummation of
the purchase and sale of the Purchased Units hereunder (the “Closing”) shall take place at the office of Vinson & Elkins L.L.P., 1001 Fannin, Suite 2500, Houston, Texas 77002, or such other location as mutually agreed by
the parties, and upon the first Business Day following the satisfaction or waiver of the conditions set forth in Sections 2.3, 2.4 and 2.5 (other than those conditions that are by their terms to be satisfied at the Closing but
subject to the satisfaction or waiver of such conditions at the Closing) or such other date as mutually agreed by the parties (the date of such closing, the “Closing Date”). The parties agree that the Closing may occur via delivery
of this Agreement and the closing deliverables contemplated hereby through facsimiles, photocopies or electronic mail or other transmission method. Unless otherwise provided herein, all proceedings to be taken and all documents to be executed and
delivered by all parties at the Closing will be deemed to have been taken and executed simultaneously, and no proceedings will be deemed to have been taken or documents executed or delivered until all have been taken, executed or delivered. 

  
 7 

 Section 2.3 Mutual Conditions. The respective obligations of each party to
consummate the purchase and sale of the Purchased Units shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions (any or all of which may be waived by a party on behalf of itself in writing, in whole
or in part, to the extent permitted by applicable Law): 
 (a) No Law shall have been enacted or promulgated, and no action shall have been
taken, by any Governmental Authority of competent jurisdiction that temporarily, preliminarily or permanently restrains, precludes, enjoins or otherwise prohibits the consummation of the transactions contemplated hereby or makes the transactions
contemplated hereby illegal; 
 (b) There shall not be pending any suit, action or proceeding by any Governmental Authority seeking to
restrain, preclude, enjoin or prohibit the transactions contemplated by this Agreement; and 
 (c) The conditions to the closing set forth in
the Purchase Agreement, dated as of the date hereof, between Crestwood Holdings LLC and the Partnership (as may be amended or modified, the “GP Transaction Agreement”), have been satisfied or validly waived and the closing thereunder shall
occur immediately following the Closing. 
 Section 2.4 Each Purchaser’s Conditions. The obligation of each
Purchaser to consummate the purchase of its Purchased Units shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions (any or all of which may be waived by a particular Purchaser on behalf of itself in
writing with respect to its Purchased Units, in whole or in part, to the extent permitted by applicable Law): 
 (a) Seller and the
Partnership shall have performed and complied with, in all material respects, the covenants and agreements contained in this Agreement that are required to be performed and complied with by Seller and the Partnership, as applicable, on or prior to
the Closing Date; 
 (b) (i) The representations and warranties of Seller and the Partnership contained in this Agreement that are
qualified by materiality shall be true and correct when made and as of the Closing Date and (ii) all other representations and warranties of the Seller and the Partnership contained in this Agreement shall be true and correct in all material
respects when made and as of the Closing Date, in each case as though made at and as of the Closing Date (except that representations and warranties made as of a specific date shall be required to be true and correct as of such date only); and 

(c) Seller shall have delivered, or caused to be delivered, to the Purchasers at the Closing, Seller’s closing deliveries described in
Section 2.6, and the Partnership shall have delivered, or cause to be delivered, to the Purchasers at the Closing, the Partnership’s closing deliverables described in Section 2.8; 

(d) No notice of delisting from the NYSE shall have been received by the Partnership with respect to the Common Units; and 

(e) No Material Adverse Effect shall have occurred and be continuing. 

  
 8 

 Section 2.5 Seller’s Conditions. The obligation of Seller to
consummate the sale of the Purchased Units to a Purchaser shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions with respect to such Purchaser (any or all of which may be waived by Seller in
writing, in whole or in part, to the extent permitted by applicable Law): 
 (a) Such Purchaser shall have performed and complied with, in
all material respects, the covenants and agreements contained in this Agreement that are required to be performed and complied with by such Purchaser on or prior to the Closing Date; 

(b) (i) The representations and warranties of such Purchaser contained in this Agreement that are qualified by materiality shall be true
and correct when made and as of the Closing Date and (ii) all other representations and warranties of such Purchaser contained in this Agreement shall be true and correct in all material respects as of the Closing Date (except that
representations of such Purchaser made as of a specific date shall be required to be true and correct as of such date only); and 
 (c) Such
Purchaser shall have delivered, or caused to be delivered, to Seller at the Closing, such Purchaser’s closing deliveries described in Section 2.7. 

Section 2.6 Seller Deliveries. At the Closing, subject to the terms and conditions hereof, Seller will deliver, or cause to be
delivered, to each Purchaser: 
 (a) An opinion addressed to the Purchasers from Simpson Thacher & Bartlett LLP, legal counsel to
Seller, dated as of the Closing, in the form and substance attached hereto as Exhibit A; 
 (b) A certificate,
dated the Closing Date and signed on behalf of the Seller by a duly authorized officer thereof, in his or her capacity as such, stating that the conditions set forth in Section 2.4(a) and
Section 2.4(b) have been satisfied; 
 (c) An executed copy of a customary payoff letter documenting (i) the
repayment of all existing third party debt for borrowed money incurred under the Credit Agreement, including all interest, premiums and fees payable in connection therewith, and (ii) the termination of all obligations of the borrower and its
subsidiaries under the Credit Agreement and related documents, the (iii) release of all guarantees and Liens granted to secure the obligations of the borrower and its subsidiaries under the Credit Agreement and (iv) the termination of the
Credit Agreement all related documents; and 
 (d) A cross-receipt executed by Seller and delivered to such Purchasers certifying that it has
received the Purchase Price from such Purchaser as of the Closing Date. 
 Section 2.7 Purchaser Deliveries. At the Closing,
subject to the terms and conditions hereof, each Purchaser will deliver, or cause to be delivered, to Seller: 
 (a) Payment to of the
Purchase Price set forth opposite such Purchaser’s name under the column titled “Commitment Amount” on Schedule A hereto by wire transfer of immediately available funds (to an account designated by Seller in writing prior to
the Closing Date); provided that such delivery shall be required only after delivery of the Purchased Units to such Purchaser in accordance with Section 2.8(a) notwithstanding anything herein to the contrary; 

  
 9 

 (b) A certificate, dated the Closing Date and signed on behalf of such Purchaser by a duly
authorized officer thereof, in his or her capacity as such, stating that the conditions set forth in Section 2.5(a) and Section 2.5(b) have been satisfied; 

(c) A cross-receipt executed by such Purchaser and delivered to Seller certifying that it has received its Purchased Units as of the Closing
Date; 
 (d) Such Purchaser’s duly executed Internal Revenue Service Form W-9; and 

(e) The Registration Rights Agreement, which shall have been duly executed by such Purchaser. 

Section 2.8 Partnership Deliveries. At the Closing, subject to the terms and conditions hereof, the Partnership will deliver, or
cause to be delivered, to each Purchaser: 
 (a) Evidence of the Purchased Units credited to book-entry accounts maintained by the transfer
agent of the Partnership registered in the name of such Purchaser or its nominee as of the Closing Date in accordance with its instructions, bearing the legend or restrictive notation set forth in Section 4.9, free and
clear of all Liens, other than transfer restrictions under the Partnership Agreement and applicable federal and state securities laws and any Liens granted to secure the obligations under the Credit Agreement which shall have been terminated and
released (or reasonable arrangements shall be in place for the termination and release of such Liens; provided that any necessary filings to record each such termination and release shall in any event be made on the Closing Date, as promptly as
practicable after the Closing, and evidence of both the filing and recording thereof shall be promptly provided in writing to each Purchaser); 

(b) The Registration Rights Agreement, which shall have been duly executed by the Partnership; 

(c) A certificate, dated the Closing Date and signed on behalf of the Partnership by a duly authorized officer thereof, in his or her capacity
as such, stating that the conditions set forth in Section 2.4(a), Section 2.4(b), Section 2.4(d), and Section 2.4(e) have been satisfied; and

 (d) A certificate of the Secretary of the General Partner, on behalf of the Partnership, certifying as to and attaching (i) the
Certificate of Limited Partnership of the Partnership and the Partnership Agreement, (ii) board resolutions authorizing the execution and delivery of the Operative Documents and the consummation of the transactions contemplated thereby,
including the issuance of the Purchased Units, and (iii) the incumbency of the officers authorized to execute the Operative Documents, setting forth the name and title and bearing the signature of such officers. 

Section 2.9 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under
this Agreement are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser under this Agreement. The failure or waiver of
performance under this Agreement by any Purchaser does not excuse performance by any other Purchaser or by the Seller with respect to the other Purchasers. It is expressly understood and agreed that each provision contained in this Agreement is
between Seller and a Purchaser, solely, and not between Seller and 

  
 10 

 
the Purchasers, collectively, and not between and among the Purchasers. Nothing contained herein, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the
Purchasers as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Purchasers are in any way acting in concert or as a group for purposes of Section 13(d) of the Exchange Act or
otherwise with respect to such obligations or the transactions contemplated by this Agreement. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement,
and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. 

ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE SELLER 

The Seller represents and warrants to each Purchaser as follows: 

Section 3.1 Existence. Seller is duly organized and validly existing and in good standing under the Laws of its jurisdiction of
organization, with all requisite power and authority to own, lease, use and operate its properties and to conduct its business as currently conducted in all material respects, except where the failure to have such power or authority would not
prevent the consummation of the transactions contemplated by this Agreement. 
 Section 3.2 Authorization, Enforceability.
Seller has all necessary corporate, limited liability company or partnership power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby, and the execution, delivery
and performance by Seller of this Agreement has been duly authorized by all necessary action on the part of Seller. This Agreement constitutes the legal, valid and binding obligation of Seller, enforceable in accordance with its terms, except as
such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer and similar laws. 
 Section 3.3 Common Unit
Ownership. 
 (a) As of the date hereof and immediately prior to the sale of Common Units pursuant to this Agreement, Seller is the
holder of record of all of the Purchased Units. Seller has, and immediately prior to the Closing will have, good and valid title to the Purchased Units. To the knowledge of the Seller, all of the Purchased Units and the limited partner interests
represented thereby have been duly authorized and validly issued in accordance with the Partnership Agreement and are fully paid (to the extent required under the Partnership Agreement) and non-assessable
(except as such non-assessability may be affected by Sections 17-303, 17-607 or 17-804 of
the Delaware LP Act). 
 (b) Upon delivery of the Purchase Price, Seller will convey to each Purchaser on the Closing Date the Purchased
Units free and clear of any Liens other than Liens set forth in the Partnership Agreement and any Liens pursuant to the Credit Agreement and related security documents, which Liens shall be terminated and released (or reasonable arrangements shall
be in place for the termination and release of such Liens; provided that any necessary filings to record each such termination and release will in any event be made on the Closing Date, as promptly as practicable after the Closing, and evidence of
both the filing and recording thereof will be promptly provided in writing to each Purchaser) as of the Closing. 

  
 11 

 Section 3.4 No Conflicts. The execution, delivery and performance by the Seller
of this Agreement, the sale of the Purchased Units and any other transactions contemplated by this Agreement will not (a) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or
result in the creation or imposition of any Lien, charge or encumbrance upon any property or assets of Seller pursuant to, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which Seller is a
party or by which Seller is bound or to which any of the property, right or assets of any of Seller is subject; (b) result in any violation of the provisions of the Organizational Documents of any of Seller; or (c) result in any violation
of any law or statute or any judgment, order, decree, rule or regulation of any court or arbitrator or governmental or regulatory authority, except, in the case of clauses (a) and (c) above, for any such conflict, breach, violation or default
that would not, individually or in the aggregate, materially impair the ability of the Seller to perform its obligations under this Agreement. 

Section 3.5 No Consents. No consent, approval, authorization or order of, or filing, registration or qualification
(“Consent”) of or with any U.S. court or arbitrator or governmental or regulatory authority is required for (a) the execution, delivery and performance by Seller of this Agreement; (b) the sale of the Purchased Units; or
(c) the consummation of the transactions contemplated by this Agreement, except (i) such as have been, or prior to the Closing Date will be, obtained or made, (ii) for the registration of the Purchased Units under the Securities Act
and Consents as may be required under applicable state securities laws and (iii) where the failure to obtain any such consent, approval, authorization or order would not, individually or in the aggregate, materially impair the ability of the
Seller to perform its obligations under this Agreement. 
 Section 3.6 No Preemptive Rights. Neither the execution of this
Agreement nor the sale of the Purchased Units as contemplated by this Agreement gives rise to any rights of first refusal, rights of first offer or similar rights under any agreement to which Seller is a party that would entitle any Person to
purchase or otherwise acquire any of the Purchased Units or require that an offer to purchase or acquire any of the Purchased Units be made to any Person. 

Section 3.7 Listing. The Common Units is registered pursuant to Section 12(b) of the Exchange Act and listed on the NYSE, and
to the knowledge of the Seller, the Partnership has (i) taken no action to terminate the registration of the Common Units under the Exchange Act or delisting the Common Units from the NYSE and (ii) not received any notification from the
SEC or the NYSE that such registration or listing is being terminated. 
 Section 3.8 Legal Proceedings. As of the date hereof,
there are no legal or governmental proceedings pending to which Seller is a party which challenges the validity of any of this Agreement or the right of Seller to enter into this Agreement or to consummate the transactions contemplated hereby and,
to the knowledge of Seller, no such proceedings are threatened by Governmental Authorities or others. 

  
 12 

 Section 3.9 Certain Fees. Other than as described in the Placement Agent
Engagement Letter, Seller is not a party to any contract, agreement or understanding (other than this Agreement) with any Person that would give rise to a valid claim against any of them or the Purchasers for a brokerage commission, finders’
fee or like payment in connection with the offering and sale of the Purchased Units for which any Purchaser could have liability. 

Section 3.10 No Side Agreements. There are no agreements by, among or between the Seller or any of its Affiliates, on the one
hand, and any Purchaser or any of their Affiliates, on the other hand, with respect to the transactions contemplated hereby other than this Agreement, nor promises or inducements for future transactions between or among any of such parties. 

Section 3.11 No Registration. Assuming the accuracy of the representations and warranties of each Purchaser contained in
Section 4.6 and Section 4.7, the sale of the Purchased Units pursuant to this Agreement is exempt from registration requirements of the Securities Act, and neither the Seller nor, to the knowledge
of the Seller, any authorized Representative acting on its behalf has taken or will take any action hereafter that would cause the loss of such exemption. 

ARTICLE IV 

REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS 

Each Purchaser, severally and not jointly, hereby represents and warrants to the Seller and the Partnership that: 

Section 4.1 Existence. Such Purchaser is duly organized and validly existing and in good standing under the Laws of its
jurisdiction of organization, with all requisite power and authority to own, lease, use and operate its properties and to conduct its business as currently conducted, except where the failure to have such power or authority would not prevent the
consummation of the transactions contemplated by this Agreement. 
 Section 4.2 Authorization, Enforceability. Such Purchaser
has all necessary corporate, limited liability company or partnership power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby, and the execution, delivery and
performance by such Purchaser of this Agreement has been duly authorized by all necessary action on the part of such Purchaser. This Agreement constitutes the legal, valid and binding obligation of such Purchaser, enforceable in accordance with its
terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer and similar laws. 
 Section 4.3
No Breach. The execution, delivery and performance of this Agreement by such Purchaser and the consummation by such Purchaser of the transactions contemplated hereby will not (a) conflict with or result in a breach or violation of any of
the terms or provisions of, or constitute a default under, any material agreement to which such Purchaser is a party or by which such Purchaser is bound or to which any of the property or assets of such Purchaser is subject, (b) conflict with
or result in any violation of the provisions of the Organizational Documents of such Purchaser, or (c) violate any statute, order, rule or regulation of any court or governmental agency or body having jurisdiction over such Purchaser or the
property or assets of such Purchaser, except in the cases of clauses (a) and (c), for such conflicts, breaches, violations or defaults as would not materially impair the ability of the such Purchaser to perform its obligations
under this Agreement. 

  
 13 

 Section 4.4 Certain Fees. No fees or commissions are or will be payable by such
Purchaser to brokers, finders, or investment bankers with respect to the purchase of any of the Purchased Units or the consummation of the transactions contemplated by this Agreement. 

Section 4.5 No Side Agreements. Other than the Operative Documents, there are no other agreements by, among or between such
Purchaser and any of its Affiliates, on the one hand, and Seller or any of its Affiliates, on the other hand, with respect to the transactions contemplated hereby, nor promises or inducements for future transactions between or among any of such
parties. 
 Section 4.6 Investment. The Purchased Units are being acquired, solely for investment with no intent to distribute,
for such Purchaser’s own account, the account of its Affiliates, or the accounts of clients for whom such Purchaser exercises discretionary investment authority (all of whom such Purchaser hereby represents and warrants are “accredited
investors” within the meaning of Rule 501(a) of Regulation D promulgated by the Commission pursuant to the Securities Act), not as a nominee or agent, and with no present intention of distributing the Purchased Units or any part thereof, and
such Purchaser has no present intention of selling or granting any participation in or otherwise distributing the same in any transaction in violation of the securities laws of the United States or any state, without prejudice, however, to
such Purchaser’s right at all times to sell or otherwise dispose of all or any part of the Purchased Units under a registration statement under the Securities Act and applicable state securities laws or under an exemption from such registration
available thereunder (including, without limitation, if available, Rule 144 promulgated thereunder). If such Purchaser should in the future decide to dispose of any of the Purchased Units, the Purchaser understands and agrees (a) that it may do
so only in compliance with the Securities Act and applicable state securities law, as then in effect, including a sale contemplated by any registration statement pursuant to which such securities are being offered, or pursuant to an exemption from
the Securities Act, and (b) that stop-transfer instructions to that effect will be in effect with respect to such securities. Notwithstanding the foregoing, each Purchaser may at any time enter into one or more over-the-counter transactions, including total return swaps, with respect to such Purchaser’s Purchased Units with a third party, provided that such transactions referencing the Common Units are exempt
from registration under the Securities Act. 
 Section 4.7 Nature of Purchaser. Such Purchaser represents and warrants to, and
covenants and agrees with, Seller that, (a) it is (i) an institutional “accredited investor” (as described in Rule 501(a)(1), (2), (3) or (7) under the Securities Act) and (ii) a qualified institutional buyer (as
defined in Rule 144A under the Securities Act), (b) by reason of its business and financial experience it has such knowledge, sophistication and experience in making similar investments and in business and financial matters generally so as to
be capable of evaluating the merits and risks of the prospective investment in the Purchased Units and (c) is able to bear the economic risk of such investment and, at the present time, would be able to afford a complete loss of such
investment. Such Purchaser did not learn of the investment in the Common Units as a result of any general solicitation or general advertising. 

  
 14 

 Section 4.8 Restricted Securities. Such Purchaser understands that the Purchased
Units are characterized as “restricted securities” under the federal securities Laws inasmuch as they are being acquired from Seller in a transaction not involving a public offering and that under such Laws and applicable regulations such
securities may not be resold absent registration under the Securities Act or an exemption therefrom. In this connection, such Purchaser represents that it is knowledgeable with respect to Rule 144 of the Commission promulgated under the Securities
Act. 
 Section 4.9 Legend. Such Purchaser understands that the book entry evidencing the Purchased Units will bear the legend
required by the Partnership Agreement as well as a legend substantively consistent with the following legend: “These securities have not been registered under the Securities Act. These securities may not be sold or offered for sale except
pursuant to an effective registration statement under the Securities Act or pursuant to an exemption from registration thereunder, in each case in accordance with all applicable securities laws of the states or other jurisdictions, and in the case
of a transaction exempt from registration, such securities may only be transferred if the transfer agent for such securities has received documentation satisfactory to it that such transaction does not require registration under the Securities
Act.” 
 Section 4.10 Partnership Information. Such Purchaser acknowledges and agrees that the Partnership has provided or
made available (through EDGAR, the Partnership’s website or otherwise) all SEC Reports, as well as all press releases or investor presentations issued by the Partnership through the date of this Agreement that are included in a filing by the
Partnership on Form 8-K or clearly posted on the Partnership’s website. 
 Section 4.11
Placement Agent Representations. 
 (a) Such Purchaser agrees that each of the Placement Agents may rely upon the
representations and warranties made by such Purchaser to Seller in this Agreement. In addition, such Purchaser acknowledges and agrees that (i) each of the Placement Agents is acting solely as a placement agent in connection with the private
placement by Seller of the Common Units contemplated hereunder and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a financial advisor or fiduciary for any Purchaser, the Seller or any other person
or entity in connection with the transactions set forth hereunder, (ii) none of the Placement Agents has made and will not make any representations, declarations or warranties, whether express or implied, of any kind or character and has not
provided any advice or recommendation to such Purchaser regarding the Seller, the Partnership or the Common Units; (iii) such Purchaser, in making its investment decision with respect to whether to invest in the Common Units offered by the
Seller hereunder has relied on its own analysis and decision, and has not relied on any of the Placement Agents or their respective representatives for any purpose; and (iv) none of the Placement Agents has offered to sell, or solicited an
offer to buy, any of the Common Units, which such Purchaser proposes to acquire from the Seller. 
 (b) Such Purchaser further acknowledges
and agrees that (A) except for the representations and warranties of the Seller and the Partnership expressly set forth in Article III and Article V, respectively, of this Agreement (it being understood that neither the Seller,
the Partnership nor any other Person acting on their behalf makes any other express or implied representation or warranty with respect to the Purchased Units), such Purchaser is relying exclusively on its own sources of information, investment
analysis and due diligence (including 

  
 15 

 
professional advice such Purchaser deems appropriate) with respect to the Purchased Units, the transactions contemplated hereunder and the business, condition (financial and otherwise),
management, operations, properties and prospects of the Partnership, including but not limited to all business, legal, regulatory, accounting, credit and tax matters, (B) no Placement Agent shall have responsibility with respect to (i) any
representations, warranties or agreements made by any person or entity under or in connection with the transactions contemplated hereunder or any of the documents furnished pursuant thereto or in connection therewith, or the execution, legality,
validity or enforceability (with respect to any person) or any thereof, or (ii) the business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the transactions contemplated hereunder, and
(C) no Placement Agent shall have any liability or obligation (including without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred
by such Purchaser, the Seller or any other person or entity), whether in contract, tort or otherwise, to such Purchaser, or to any person claiming through such Purchaser, in respect of the transactions contemplated hereunder. 

(c) Such Purchaser has (i) had access to and an adequate opportunity to review such financial and other information as such Purchaser
deems necessary to make a decision to purchase the Common Units, (ii) been offered the opportunity to ask questions of the Partnership and received answers thereto, including on the Partnership’s financial information, as such Purchaser
deemed necessary in connection with its decision to purchase the Common Units; and (iii) made its own assessment and satisfied itself concerning the relevant tax and other economic considerations relevant to its purchase of Common Units. 

(d) Such Purchaser further acknowledges and agrees that (i) Seller, the Partnership and the Placement Agents may currently have, and later
may come into possession of, information regarding the Partnership that is not known to such Purchaser and that may be material to a decision to purchase the Common Units (“Excluded Information”), (ii) such Purchaser has determined
to purchase the Common Units notwithstanding its potential lack of knowledge of the Excluded Information, and (iii) except with respect to the Seller in connection with any breach by the Seller of Article III or with
respect to the Partnership in connection with any breach by the Partnership of Article V, none of Seller, the Partnership or the Placement Agents shall have liability to such Purchaser, and such Purchaser hereby, to the
extent permitted by law, waives and releases any claims such Purchaser may have against Seller, the Partnership and the Placement Agents, in each case with respect to the nondisclosure of the Excluded Information. 

(e) Such Purchaser further acknowledges and agrees that (i) certain information provided to such Purchaser was based on good-faith
projections, and such good-faith projections were prepared based on assumptions and estimates that are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties that could cause
actual results to differ materially from those contained in such good-faith projections, and (ii) such information and good-faith projections were prepared without the participation of the Placement Agents, and the Placement Agents are not
responsible for verification of, or the accuracy or completeness of, such information or good-faith projections. 

  
 16 

 (f) Such Purchaser further acknowledges and agrees that the Placement Agents and their
respective Representatives and controlling persons have made no independent investigation with respect to the Partnership or the Common Units or the accuracy, completeness or adequacy of any information supplied to such Purchaser by the Seller or
the Partnership. No disclosure or offering document has been prepared by the Placement Agents in connection with the offer and sale of Common Units contemplated by this Agreement. 

(g) Such Purchaser understands that the offer and sale of Common Units contemplated by this Agreement qualifies for exemption from filing under
FINRA Rule 5123(b)(1)(C) or (J). 
 (h) Such Purchaser (i) is an “institutional account” as defined in FINRA Rule 4512(c),
(ii) is a sophisticated investor, experienced in investing in private equity transactions and capable of evaluating investment risks independently, both in general and with regard to all transactions and investment strategies involving a security or
securities, and (iii) has exercised independent judgment in evaluating its participation in the purchase of the Common Units. Such Purchaser understands that the offer and sale of Common Units contemplated by this Agreement qualifies for
exemption from filing under FINRA Rule 5123(b)(1)(A) and the institutional customer exemption under FINRA Rule 2111(b). 
 Section 4.12
Short Selling. Such Purchaser represents that it has not entered into any Short Sales of the Common Units owned by it since the time it first began discussions with the Seller or the Placement Agents about the transactions contemplated by
this Agreement; provided, however, subject to such Purchaser’s compliance with its obligations under the U.S. federal securities laws and its internal policies, the above shall not apply, in the case of a Purchaser that is a large
multi-unit investment or commercial banking organization, to activities in the normal course of trading units of such Purchaser; provided, further, that subject to such Purchaser’s compliance with its obligations under the U.S. federal
securities laws and its internal policies: (a) such Purchaser, for purposes hereof, shall not be deemed to include any employees, subsidiaries or Affiliates that are effectively walled off by appropriate “Chinese Wall” information
barriers approved by such Purchaser’s legal or compliance department (and thus have not been privy to any information concerning this transaction) (a “Walled Off Person”) and (b) the foregoing representations in this
paragraph shall not apply to any transaction by or on behalf of such Purchaser that was effected by a Walled Off Person in the ordinary course of trading without the advice or participation of such Purchaser or receipt of confidential or other
information regarding this transaction provided by such Purchaser to such entity. 
 ARTICLE V 

REPRESENTATIONS AND WARRANTIES OF THE PARTNERSHIP 

The Partnership represents and warrants to each Purchaser as follows: 

Section 5.1 Existence. The Partnership is duly organized and validly existing and in good standing under the Laws of its
jurisdiction of organization, with all requisite power and authority to own, lease, use and operate its properties and to conduct its business as currently conducted in all material respects, except where the failure to have such power or authority
would not, individually or in the aggregate, (a) have a material adverse effect on the business, properties, management, financial position or results of operations of the Partnership and its Subsidiaries and Affiliates taken as a whole;
(b) materially impair the ability of the Partnership to consummate the transactions contemplated by the GP Transaction Agreement or to perform its obligations under this Agreement or the GP Transaction Agreement (each of clause (a) and
(b), a “Material Adverse Effect”); or (c) subject the limited partners of the Partnership to any material liability or disability. 

  
 17 

 Section 5.2 Authorization, Enforceability. The Partnership has all necessary
corporate, limited liability company or partnership power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated hereby, and the execution, delivery and performance by the
Partnership of this Agreement has been duly authorized by all necessary action on the part of Partnership. This Agreement constitutes the legal, valid and binding obligation of the Partnership, enforceable in accordance with its terms, except as
such enforceability may be limited by (i) bankruptcy, reorganization, insolvency, fraudulent conveyance, moratorium or other laws affecting creditors’ rights generally from time to time in effect, (ii) general principles of equity
(whether considered in a proceeding in equity or at law) and (iii) an implied covenant of good faith and fair dealing (collectively, the “Enforceability Limitations”). 

Section 5.3 No Conflicts. The execution, delivery and performance by the Partnership of this Agreement and any transactions
contemplated by this Agreement and the GP Transaction Agreement will not (a) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or result in the creation or imposition of any
Lien, charge or encumbrance upon any property or assets of the Partnership or its Subsidiaries pursuant to, any indenture, mortgage, deed of trust, loan agreement, license, lease or other agreement or instrument to which the Partnership or its
Subsidiaries or Affiliates is a party or by which the Partnership or its Subsidiaries or Affiliates is bound or to which any of the property, right or assets of the Partnership or its Subsidiaries or Affiliates is subject (other than Liens created,
arising under or securing the Credit Agreement); (b) result in any violation of the provisions of the Organizational Documents of the Partnership or its Subsidiaries or Affiliates; or (c) result in any violation of any Law, rule or
regulation or any order, judgment, decree or injunction of any court or arbitrator or governmental agency or body directed to the Partnership or its Subsidiaries or any of their properties in a proceeding to which any of them or their property is a
party, except, in the case of clauses (a) and (c) above, for any such conflict, breach, violation or default that would not, individually or in the aggregate, have a Material Adverse Effect. 

Section 5.4 No Consents. No Consent of or with any U.S. court or arbitrator or Governmental Authority or regulatory authority
having jurisdiction over any of the Partnership, including, without limitation, the NYSE, is required for (a) the execution, delivery and performance by the Partnership of this Agreement; or (b) the consummation of the transactions
contemplated by this Agreement or the GP Transaction Agreement, except (i) such as have been, or prior to the Closing Date will be, obtained or made, (ii) for the registration of the Purchased Units under the Securities Act and Consents as
may be required under applicable state securities laws and (iii) where the failure to obtain any such consent, approval, authorization or order would not, individually or in the aggregate, have a Material Adverse Effect. 

Section 5.5 Duly Authorized and Validly Issued Units. All of the Purchased Units and the limited partner interests represented
thereby have been duly authorized and validly issued in accordance with the Partnership Agreement and are fully paid (to the extent required under the Partnership Agreement) and non-assessable (except as such non-assessability may be affected by Sections 17-303, 17-607 or 17-804 of the Delaware LP Act).

  
 18 

 Section 5.6 Listing. The Common Units are registered pursuant to
Section 12(b) of the Exchange Act and listed on the NYSE, and the Partnership has (i) taken no action to terminate the registration of the Common Units under the Exchange Act or delisting the Common Units from the NYSE and (ii) not
received any notification from the Commission or the NYSE that such registration or listing is being terminated. 
 Section 5.7
Legal Proceedings. Except as disclosed in the SEC Reports, there is no action, suit, proceeding, inquiry or investigation before or brought by any court or Governmental Authority, domestic or foreign, now pending, or, to the knowledge of the
Partnership, threatened, against or affecting the Partnership or its Subsidiaries or Affiliates, which (a) could reasonably be expected to result in a Material Adverse Effect, (b) could reasonably be expected to materially and adversely
affect the properties or assets of the Partnership and the Subsidiaries taken as a whole or (c) could reasonably be expected to materially and adversely affect the consummation of the transactions contemplated in this Agreement, the
transactions contemplated by the GP Transaction Agreement or the performance by the Partnership of the obligations contemplated hereunder and thereunder. The aggregate of all pending legal or governmental proceedings to which any of the Partnership
or its Subsidiaries or Affiliates is a party or of which any of their respective property or assets is the subject that are not described in the SEC Reports, including ordinary routine litigation incidental to the business, could not reasonably be
expected to result in a Material Adverse Effect. 
 Section 5.8 No Defaults. None of the Partnership or its Subsidiaries or
Affiliates is (a) in violation of its Organizational Documents; (b) in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term,
covenant or condition contained in any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which any of the Partnership or its Subsidiaries or Affiliates is a party or by which the Partnership is bound or to which
any of the property or assets of the Partnership is subject; or (c) in violation of any law, statute, ordinance, administrative or governmental rule or regulation applicable to it or of any decree of any court or governmental agency or body
having jurisdiction over it; except, in the case of clauses (b) and (c) above, for any such default or violation that would not, have a Material Adverse Effect. 

Section 5.9 No Registration Rights. Except as disclosed in the SEC Reports or as contemplated by this Agreement and the
Registration Rights Agreement or pursuant to the Partnership Agreement, there are no contracts, agreements or understandings between any of the Partnership and any Person granting such Person the right to require the Partnership to file a
registration statement under the Securities Act with respect to any securities of the Partnership owned or to be owned by such Person or to require the Partnership to include such securities in the Registration Statement or in any securities
registered or to be registered pursuant to any registration statement filed by or required to be filed by the Partnership under the Securities Act. 

  
 19 

 Section 5.10 Periodic Reports. The SEC Reports have been filed with the
Commission on a timely basis. The SEC Reports, including, without limitation, any audited or unaudited financial statements and any notes thereto or schedules included therein, at the time filed (or in the case of registration statements, solely on
the dates of effectiveness) (except to the extent corrected by a subsequent SEC Report) (a) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading and (b) complied in all material respects with the applicable requirements of the Exchange Act and the Securities Act, as the case may be. 

Section 5.11 Financial Statements. The historical financial statements of the Partnership (including its predecessor for
accounting purposes) and subsidiaries (including the related notes and supporting schedules) included in the SEC Reports comply as to form in all material respects with the requirements of Regulation S-X under
the Securities Act and present fairly in all material respects the financial condition, results of operations and cash flows of the entities purported to be shown thereby at the dates and for the periods indicated and have been prepared in
conformity with accounting principles generally accepted in the United States applied on a consistent basis throughout the periods involved. 

Section 5.12 No Material Changes. Since the date of the most recent audited financial statements included in the SEC Reports,
except as may otherwise be stated therein or contemplated thereby, none of the Partnership or its Subsidiaries or Affiliates has (a) sustained any loss or interference with its business from fire, explosion, flood or other calamity, whether or
not covered by insurance, or from any labor dispute or court or governmental action, order or decree, (b) issued or granted any securities, (c) incurred any material liability or obligation, direct or contingent, other than liabilities and
obligations that were incurred in the ordinary course of business, (d) entered into any material transaction not in the ordinary course of business, or (e) declared or paid any distribution or dividend on its equity interests, and since
such date, there has not been any change in the equity interests or long-term debt of any of the Partnership or its Subsidiaries or Affiliates or any adverse change, or any development involving a prospective adverse change, in or affecting the
condition (financial or otherwise), results of operations, partners’ equity, properties, management, business or prospects of the Partnership and its Subsidiaries and Affiliates taken as a whole, in each case, except as could not, in the
aggregate, reasonably be expected to have a Material Adverse Effect. 
 Section 5.13 Investment Company. The Partnership is not
and, as of the Closing Date will not be, (i) an “investment company” or a company “controlled” by an “investment company” within the meaning of the Investment Company Act of 1940, as amended, and the rules and
regulations of the Commission thereunder (collectively, the “Investment Company Act”) or (ii) a “business development company” (as defined in Section 2(a)(48) of the Investment Company Act). 

Section 5.14 No Unlawful Payments. None of the Partnership or its Subsidiaries (the “Partnership Entities”) nor any
director or officer of any of the Partnership Entities, nor, to the knowledge of any of the Partnership Entities, any agent, employee or affiliate of any of the Partnership Entities, is aware of or has taken or will take any action, directly or
indirectly, that would result in a violation by such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the “FCPA”), or any other applicable anti-corruption or
anti-bribery laws, including, without limitation, making use of the mails or any means or instrumentality of interstate commerce corruptly in furtherance of an offer, 

  
 20 

 
payment, promise to pay, or authorization or approval of the payment or giving of money, property, gifts or anything else of value, directly or indirectly, to any “foreign official” (as
such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA or any other applicable anti-corruption or anti-bribery laws; and each of the
Partnership Entities and, to the knowledge of the Partnership Entities, their respective affiliates, have conducted their businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to promote and achieve
compliance therewith and with the representation and warranty contained herein.. 
 Section 5.15 Compliance with Money Laundering
Laws. The operations of each of the Partnership Entities are and have been conducted at all times in compliance with the applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of
1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency
(collectively, the “Money Laundering Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving any of the Partnership Entities with respect to the Money Laundering
Laws is pending or, to the knowledge of any of the Partnership Entities, threatened. 
 Section 5.16 OFAC. None of the
Partnership Entities, nor any director or officer thereof, nor, to the knowledge of any of the Partnership Entities, any employee, agent, controlled affiliate or representative of any of the Partnership Entities, is an individual or entity
(“Person”) that is, or is owned or controlled by a Person that is currently subject to, any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”) or any other applicable
sanction laws; and each of the Partnership Entities will not directly or indirectly use the proceeds of the offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person, to
(i) fund or facilitate any activities or business of or with any Person that, at the time of such funding or facilitation, is subject to any U.S. sanctions administered by OFAC or any other applicable sanctions laws or (ii) in any other
manner that will result in a violation of any U.S. sanctions administered by OFAC or any other applicable sanctions laws by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). 

ARTICLE VI 

COVENANTS 

Section 6.1 Taking of Necessary Action. Each of the parties hereto shall use its commercially reasonable efforts promptly to take
or cause to be taken all action and promptly to do or cause to be done all things necessary, proper or advisable under applicable Law and regulations to consummate and make effective the transactions contemplated by this Agreement and, with respect
to the Partnership, the GP Transaction Agreement. Notwithstanding anything to the contrary, no Purchaser is under any obligation by reason of this Section 6.1 to make, seek or receive any filings, notifications, consents,
determinations, authorizations, permits, approvals, licenses or the like with or provide any documentation or information to any regulatory or self-

  
 21 

 
regulatory body having jurisdiction over the Partnership or Purchaser other than information that is already included in this Agreement or is otherwise in the public domain other than as may be
requested by the Commission or pursuant to any applicable securities or “Blue Sky” laws of the United States. The Partnership shall promptly and accurately respond, and shall use its commercially reasonable efforts to cause its transfer
agent to respond, to reasonable requests for information (which is otherwise not publicly available) made by a Purchaser or its auditors relating to the actual holdings of such Purchaser or its accounts; provided, that the Partnership shall not be
obligated to provide any such information that could reasonably result in a violation of applicable Law or conflict with the Partnership’s insider trading policy or a confidentiality obligation of the Partnership. The Partnership shall use its
commercially reasonable efforts to cause its transfer agent to reasonably cooperate with each Purchaser to ensure that the Purchased Units are validly and effectively issued to such Purchaser and that such Purchaser’s ownership of the Purchased
Units following the Closing is accurately reflected on the appropriate books and records of the Partnership’s transfer agent. 

Section 6.2 Registration Rights Agreement. Concurrently with Closing, the Partnership and each Purchaser shall enter into a
Registration Rights Agreement in substantially the form attached hereto as Exhibit B. 
 Section 6.3 Lock-Up. The Partnership, without the prior written consent of each Purchaser, will not, during the period ending 60 days after the date of this Agreement (the “Restricted Period”), (a) sell,
transfer or dispose of, directly or indirectly, any Common Units or any securities convertible into or exercisable or exchangeable for Common Units, or (b) enter into any swap or other arrangement that transfers to another, in whole or in part,
any of the economic consequences of ownership of the Common Units; provided that nothing herein shall restrict the Partnership from contracting to sell Common Units or any securities convertible into or exercisable or exchangeable for Common Units
so long as the actual sale of such securities occurs subsequent to the Restricted Period. The restrictions contained in the foregoing sentence shall not apply to (A) the Common Units to be sold hereunder, (B) the issuance by the
Partnership of Common Units upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof, or (C) facilitating the establishment of a trading plan on behalf of a unitholder, officer or director of the
Partnership pursuant to Rule 10b5-1 under the Exchange Act, for the transfer of Common Units, provided that (i) such plan does not provide for the transfer of Common Units during the Restricted Period and
(ii) to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by the Partnership regarding the establishment of such plan, such announcement or filing shall include a statement to the
effect that no transfer of Common Units may be made under such plan during the Restricted Period. 
 Section 6.4 Non-Public Information. On or before 8:30 a.m., New York local time, on the Business Day immediately following the date hereof, the Partnership shall issue a press release (the “Press Release”)
announcing the entry into this Agreement, the Registration Rights Agreement and the GP Transaction Agreement and describing the terms of the transactions contemplated hereby and thereby and any other material, nonpublic information that the
Partnership may have provided any Purchaser at any time prior to the issuance of the Press Release. On or before the fourth Business Day following the date hereof, the Partnership shall file a Current Report on Form
8-K with the Commission describing the terms of the transactions contemplated by this Agreement, the Registration Rights Agreement and the GP Transaction Agreement, and including as an exhibit to such Current
Report on Form 8-K this Agreement, the Registration Rights Agreement and the GP Transaction Agreement, in the form required by the Exchange Act. 

  
 22 

 Section 6.5 Use of Proceeds. No part of the proceeds from the sale of the
Purchased Units shall be delivered or paid, directly or indirectly, to The Goldman Sachs Group, Inc., Goldman Sachs Asset Management, L.P. or any of their respective Affiliates. 

ARTICLE VII 

INDEMNIFICATION 

Section 7.1 Indemnification by Seller. From and after the Closing, the Seller agrees to indemnify each Purchaser and its
Representatives (collectively, “Purchaser Related Parties”) from, and hold each of them harmless against, any and all actions, suits, proceedings (including any investigations, litigation or inquiries), demands, and causes of
action, and, in connection therewith, and promptly upon demand, pay or reimburse each of them for all costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever, including, without limitation, the reasonable fees and
disbursements of counsel and all other reasonable expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or involve any of them as a result of, arising
out of, or in any way related to the breach of any of the representations, warranties or covenants of Seller contained herein, provided that such claim for indemnification relating to a breach of the representations or warranties is made
prior to the expiration of the survival period for such representations or warranties; and provided further, that no Purchaser Related Party shall be entitled to recover special, consequential (including lost profits) or punitive damages.
Notwithstanding anything to the contrary, consequential damages shall not be deemed to include diminution in value of the Purchased Units, which is specifically included in damages covered by Purchaser Related Parties’ indemnification above.

 Section 7.2 Indemnification by the Partnership. From and after the Closing, the Partnership agrees to indemnify each
Purchaser Related Party from, and hold each of them harmless against, any and all actions, suits, proceedings (including any investigations, litigation or inquiries), demands, and causes of action, and, in connection therewith, and promptly upon
demand, pay or reimburse each of them for all costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever, including, without limitation, the reasonable fees and disbursements of counsel and all other reasonable expenses
incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or involve any of them as a result of, arising out of, or in any way related to the breach of any of the
representations, warranties or covenants of the Partnership contained herein, provided that such claim for indemnification relating to a breach of the representations or warranties is made prior to the expiration of the survival period for
such representations or warranties; and provided further, that no Purchaser Related Party shall be entitled to recover special, consequential (including lost profits) or punitive damages. Notwithstanding anything to the contrary,
consequential damages shall not be deemed to include diminution in value of the Purchased Units, which is specifically included in damages covered by Purchaser Related Parties’ indemnification above. 

  
 23 

 Section 7.3 Indemnification by Purchasers. From and after the Closing, each
Purchaser agrees, severally and not jointly, to indemnify Seller and its Representatives (collectively, “Seller Related Parties”) from, and hold each of them harmless against, any and all actions, suits, proceedings (including any
investigations, litigation or inquiries), demands, and causes of action, and, in connection therewith, and promptly upon demand, pay or reimburse each of them for all costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever,
including, without limitation, the reasonable fees and disbursements of counsel and all other reasonable expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted
against or involve any of them as a result of, arising out of, or in any way related to the breach of any of the representations, warranties or covenants of such Purchaser contained herein, provided that such claim for indemnification relating to a
breach of the representations and warranties is made prior to the expiration of the survival period for such representations and warranties; and provided further, that Seller shall not be entitled to recover special, consequential (including lost
profits) or punitive damages. 
 Section 7.4 Indemnification Procedure. Promptly after receipt by an indemnified party under
this Article VII of notice of any claim or the commencement of any action, the indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under this
Article VII, notify the indemnifying party in writing of the claim or the commencement of that action; provided, however, that the failure to notify the indemnifying party shall not relieve it from any liability
which it may have under this Article VII except to the extent it has been materially prejudiced (through the forfeiture of substantive rights and defenses) by such failure and, provided, further, that the failure to
notify the indemnifying party shall not relieve it from any liability which it may have to an indemnified party otherwise than under this Article VII. If any such claim or action shall be brought against an indemnified
party, and it shall notify the indemnifying party thereof, the indemnifying party shall be entitled to participate therein and, to the extent that it wishes, jointly with any other similarly notified indemnifying party, to assume the defense thereof
with counsel reasonably satisfactory to the indemnified party. After notice from the indemnifying party to the indemnified party of its election to assume the defense of such claim or action, the indemnifying party shall not be liable to the
indemnified party under this Article VII for any legal or other expenses subsequently incurred by the indemnified party in connection with the defense thereof other than reasonable costs of investigation; provided,
however, that the indemnified party shall have the right to employ counsel to represent jointly the indemnified party and those other indemnified parties and their respective directors, officers, employees and controlling persons who may be
subject to liability arising out of any claim in respect of which indemnity may be sought under this Article VII if (a) the indemnified party and the indemnifying party shall have so mutually agreed; (b) the
indemnifying party has failed within a reasonable time to retain counsel reasonably satisfactory to the indemnified party; (c) the indemnified party and its directors, officers, employees and controlling persons shall have reasonably concluded
that there may be legal defenses available to them that are different from or in addition to those available to the indemnifying party; or (d) the named parties in any such proceeding (including any impleaded parties) include both the
indemnified parties or their respective directors, officers, employees or controlling persons, on the one hand, and the indemnifying party, on the other hand, and representation of both sets of parties by the same counsel would be inappropriate due
to actual or potential differing interests between them, and in any such event the fees and expenses of such separate counsel shall be paid by the indemnifying party. No indemnifying party shall (i) without the prior written consent of the
indemnified parties (which consent shall not be unreasonably 

  
 24 

 
withheld), settle or compromise or consent to the entry of any judgment with respect to any pending or threatened claim, action, suit or proceeding in respect of which indemnification or
contribution may be sought hereunder (whether or not the indemnified parties are actual or potential parties to such claim or action) unless such settlement, compromise or consent includes an unconditional release of each indemnified party from all
liability arising out of such claim, action, suit or proceeding and does not include a statement as to, or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party, or (ii) be liable for any settlement of
any such action effected without its written consent (which consent shall not be unreasonably withheld), but if settled with the consent of the indemnifying party or if there be a final judgment for the plaintiff in any such action, the indemnifying
party agrees to indemnify and hold harmless any indemnified party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an
indemnifying party to reimburse the indemnified party for fees and expenses of counsel to the extent required by this Section 7.1, the indemnifying party agrees that it shall be liable for any settlement of any proceeding
effected without its written consent if (x) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (y) such indemnifying party shall not have reimbursed the indemnified party
in accordance with such request or disputed in good faith the indemnified party’s entitlement to such reimbursement prior to the date of such settlement. 

ARTICLE VIII 

MISCELLANEOUS 

Section 8.1 Interpretation. Article, Section, Schedule, and Exhibit references are to this Agreement, unless otherwise specified.
All references to instruments, documents, contracts, and agreements are references to such instruments, documents, contracts, and agreements as the same may be amended, supplemented, and otherwise modified from time to time, unless otherwise
specified. The word “including” shall mean “including but not limited to.” Whenever any party has an obligation under this Agreement, the expense of complying with that obligation shall be an expense of such party unless
otherwise specified. Whenever any determination, consent, or approval is to be made or given by any Purchaser, such action shall be in such Purchaser’s sole discretion unless otherwise specified in this Agreement. If any provision in this
Agreement is held to be illegal, invalid, not binding, or unenforceable, such provision shall be fully severable and this Agreement shall be construed and enforced as if such illegal, invalid, not binding, or unenforceable provision had never
comprised a part of this Agreement, and the remaining provisions shall remain in full force and effect. This Agreement has been reviewed and negotiated by sophisticated parties with access to legal counsel and shall not be construed against the
drafter. 
 Section 8.2 Survival of Provisions. The representations and warranties set forth in Sections 3.1, 3.2,
3.3, 3.6, 3.9, 3.11, 5.1, 5.2 and 5.5 shall survive indefinitely, Sections 3.4, 3.5, 3.7, 4.2, 4.3, 4.4, 4.5, 4.7, 4.8, 4.9,
4.11, 5.9 and 5.12 shall survive until the second anniversary of the Closing Date, and the other representations and warranties set forth herein shall survive for a period of twelve (12) months following the Closing Date
regardless of any investigation made by or on behalf of the Seller, the Partnership or any Purchaser. The covenants made in this Agreement shall survive the Closing of the transactions described herein and remain operative and in full force and
effect regardless of acceptance of any of the Purchased Units and payment therefor and repayment, conversion, exercise or repurchase thereof. All indemnification obligations of the Seller, the Partnership and the Purchasers pursuant to this
Agreement and the provisions of Article VII shall remain operative and in full force and effect unless such obligations are expressly terminated in a writing by the parties, regardless of any purported general termination
of this Agreement. 

  
 25 

 Section 8.3 No Waiver; Modifications in Writing. 

(a) Delay. No failure or delay on the part of any party in exercising any right, power, or remedy hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such right, power, or remedy preclude any other or further exercise thereof or the exercise of any other right, power, or remedy. The remedies provided for herein are cumulative and are not
exclusive of any remedies that may be available to a party at law or in equity or otherwise. 
 (b) Specific Waiver. Except as
otherwise provided herein, no amendment, waiver, consent, modification, or termination of any provision of this Agreement shall be effective unless signed by each of the parties hereto. Any amendment, supplement or modification of or to any
provision of this Agreement, any waiver of any provision of this Agreement, and any consent to any departure by the Seller from the terms of any provision of this Agreement shall be effective only in the specific instance and for the specific
purpose for which made or given. Except where notice is specifically required by this Agreement, no notice to or demand on a party in any case shall entitle such party to any other or further notice or demand in similar or other circumstances. 

Section 8.4 Binding Effect; Assignment. 

(a) Binding Effect. This Agreement shall be binding upon the Partnership, the Seller, the Purchasers, and their respective successors
and permitted assigns. Except as expressly provided in this Agreement, this Agreement shall not be construed so as to confer any right or benefit upon any Person other than the parties to this Agreement and their respective successors and permitted
assigns. 
 (b) Assignment of Rights. All or any portion of the rights and obligations of any Purchaser under this Agreement may be
transferred by such Purchaser to any Affiliate of such Purchaser without the consent of the Seller. No portion of the rights and obligations of any Purchaser under this Agreement may be transferred by such Purchaser to a non-Affiliate without the written consent of the Seller (which consent shall not be unreasonably withheld by the Seller); provided that, no assignment shall relieve the transferring Purchaser of its obligations
hereunder. 
 Section 8.5 Confidentiality. Notwithstanding anything herein to the contrary, to the extent that any Purchaser has
executed or is otherwise bound by a confidentiality agreement in favor of the Seller, such Purchaser shall continue to be bound by such confidentiality agreement in accordance with the terms thereof. 

Section 8.6 Communications. All notices and demands provided for hereunder shall be in writing and shall be given by registered or
certified mail, return receipt requested, electronic mail, air courier guaranteeing overnight delivery or personal delivery to the following addresses: 

  
 26 

 (a) If to any Purchaser, to the respective address listed on Schedule A hereto; and

 (b) If to Seller, to: 
 Crestwood Gas
Services Holdings LLC 
 811 Main Street, Suite 3400 
 Houston,
Texas 77002 
 Attn: General Counsel 
 Fax No.: (832) 519-2250 
 with a copy to: 

Vinson & Elkins LLP 
 1001 Fannin Street, Suite 2500

 Houston, Texas 77002 
 Attention: Gillian A. Hobson 

Facsimile: (713) 758-2222 

Email: ghobson@velaw.com; 
 or to such other address as the
Seller or such Purchaser may designate in writing. All notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; at the time of transmittal, if sent via electronic mail; upon actual
receipt if sent by certified mail, return receipt requested, or regular mail, if mailed; when receipt acknowledged, if sent via facsimile; and upon actual receipt when delivered to an air courier guaranteeing overnight delivery. 

Section 8.7 Removal of Legend. The Partnership, at its sole cost, shall remove the legend described in
Section 4.9 (or instruct its transfer agent to so remove such legend) from the certificates evidencing Purchased Units issued and sold to each Purchaser pursuant to this Agreement if (a) such Purchased Units are sold
pursuant to an effective registration statement under the Securities Act, (b) such Purchased Units are sold or transferred pursuant to Rule 144 (if the transferor is not an Affiliate of the Partnership), or (c) such Purchased Units are
eligible for sale under Rule 144, without the requirement for the Partnership to be in compliance with the current public information required under Rule 144(c)(1) (or Rule 144(i)(2), if applicable) as to such securities and without volume or manner
of sale restrictions. In connection with a sale of the Purchased Units by a Purchaser in reliance on Rule 144, the applicable Purchaser shall deliver to the transfer agent and the Partnership a customary representation letter providing to the
transfer agent and the Partnership any information the Partnership deems reasonably necessary to determine that the sale of the Purchased Units is made in compliance with Rule 144, including, as may be appropriate, a certification that the Purchaser
is not an Affiliate of the Partnership and regarding the length of time the Purchased Units have been held. Upon receipt of such representation letter, the Partnership shall promptly direct its transfer agent to remove the legend referred to in
Section 4.9 from the appropriate book-entry accounts maintained by the transfer agent, and the Partnership shall bear all costs associated therewith. After any Purchaser or its permitted assigns have held the Purchased
Units for such time as non-Affiliates are permitted to sell without volume limitations under Rule 144, if the certificate for such Purchased Units still 

  
 27 

 
bears the restrictive legend referred to in Section 4.9, the Partnership agrees, upon request of the Purchaser or permitted assignee, to take all steps necessary to
promptly effect the removal of the legend described in Section 4.9 from the Purchased Units, and the Partnership shall bear all costs associated therewith, regardless of whether the request is made in connection with a sale
or otherwise, so long as such Purchaser or its permitted assigns provide to the Partnership any information the Partnership deems reasonably necessary to determine that the legend is no longer required under the Securities Act or applicable state
laws, including a certification that the holder is not an Affiliate of the Partnership (and a covenant to inform the Partnership if it should thereafter become an Affiliate and to consent to exchange its certificates for certificates bearing an
appropriate restrictive legend) and regarding the length of time the Purchased Units have been held. 
 Section 8.8 Most Favored
Nation. During the period from the date of this Agreement through the Closing Date, if any of the Partnership or its Subsidiaries shall enter into any additional, or modify any existing, agreements with any existing or future investors in
any of the Partnership or its Subsidiaries that have the effect of establishing rights or otherwise benefiting such investor in a manner more favorable in any material respect to such investor than the rights and benefits established in favor of the
Purchasers by this Agreement, in any such case, the Purchasers shall be provided with such rights and benefits. 
 Section 8.9
Entire Agreement. This Agreement is intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject
matter contained herein and therein. There are no restrictions, promises, representations, warranties or undertakings, other than those set forth or referred to herein with respect to the rights granted by the Seller or any of its Affiliates or any
Purchaser or any of its Affiliates set forth herein or therein. This Agreement supersedes all prior agreements and understandings between the parties with respect to such subject matter. 

Section 8.10 Expenses. Each Purchaser agrees that it shall bear its own costs and expenses incurred or to be incurred by it in the
preparation and negotiation of this Agreement and in carrying out the transactions contemplated hereby, regardless of whether such transactions are ultimately consummated. 

Section 8.11 Acknowledgement. The parties acknowledge and agree that, although the Placement Agents may provide certain Regulation
Best Interest and Form CRS disclosures or other related documentation in connection with the transactions contemplated by this Agreement, the Placement Agents make no recommendation with regard to such transactions, and nothing set forth in such
disclosures or documentation is intended to suggest that any Placement Agent is making such a recommendation 
 Section 8.12
Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflict of laws principles (other than Section 5-1401 of the
General Obligations Law). 

  
 28 

 Section 8.13 Execution in Counterparts. This Agreement may be executed in any
number of counterparts and by different parties hereto in separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts, taken together, shall constitute but one
and the same Agreement. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 

Section 8.14 Termination. 

(a) Notwithstanding anything herein to the contrary, this Agreement may be terminated at any time at or prior to the Closing by any Purchaser
(with respect to such Purchaser only), upon (i) a breach in any material respect by the Seller or the Partnership of any covenant or agreement set forth in this Agreement or (ii) termination of the GP Transaction Agreement. 

(b) Notwithstanding anything herein to the contrary, this Agreement may be terminated at any time at or prior to the Closing by the Seller,
upon (i) a breach in any material respect by any Purchaser of any covenant or agreement set forth in this Agreement or (ii) termination of the GP Transaction Agreement. 

(c) Notwithstanding anything herein to the contrary, this Agreement shall automatically terminate at any time at or prior to the Closing if a
statute, rule, order, decree or regulation shall have been enacted or promulgated, or if any action shall have been taken by any Governmental Authority of competent jurisdiction that permanently restrains, permanently precludes, permanently enjoins
or otherwise permanently prohibits the consummation of the transactions contemplated by this Agreement or makes the transactions contemplated by this Agreement illegal. 

(d) In the event of the termination of this Agreement as provided in this Section 8.13, subject to the ultimate
sentence of Section 8.2, this Agreement shall forthwith become null and void. In the event of such termination, subject to the ultimate sentence of Section 8.2, there shall be no liability on the
part of any party hereto; provided that nothing herein shall relieve any party from any liability or obligation with respect to any willful breach of covenants set forth in this Agreement. 

[Signature pages to follow] 

  
 29 

 IN WITNESS WHEREOF, the parties hereto execute this Agreement, effective as of the date first above written.

  

			
	SELLER:
	
	CRESTWOOD GAS SERVICES HOLDINGS LLC
		
	By:	 	 /s/ Gary Reaves

	Name:	 	Gary Reaves
	Title:	 	Authorized Signatory

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	PURCHASERS:
	
	Brookfield Public Securities Group LLC, as
	Investment Advisor for:
	
	 •  Center Coast Brookfield Midstream Focus Fund

	 •  Center Coast Brookfield Capital Partners, LP

		
	By:	 	 /s/ Brian Hourihan

	Name:	 	Brian Hourihan
	Title:	 	Managing Director, Chief Compliance Officer & Regulatory Counsel
	
	CHICKASAW CAPITAL MANAGEMENT, LLC,
	as discretionary manager on behalf of:
	
	MainGate MLP Fund
	Chickasaw MLP Partners, LLC
		
	By:	 	 /s/Geoffrey P. Mavar

	Name:	 	Geoffrey P. Mavar
	Title:	 	Principal
	
	Atlas Point Energy Infrastructure Fund, LLC
		
	By:	 	 /s/ Chris Linder

	Name:	 	Chris Linder
	Title:	 	Managing Director

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	CLEARBRIDGE ENERGY MIDSTREAM OPPORTUNITY FUND INC.
		
	By:	 	ClearBridge Investments, LLC as
		 	discretionary manager
		
	By:	 	 /s/ Barbara Brooke Manning

	Name:	 	Barbara Brooke Manning
	Title:	 	Managing Director
	
	CLEARBRIDGE MLP AND MIDSTREAM
	FUND INC.
		
	By:	 	ClearBridge Investments, LLC as
		 	discretionary manager
		
	By:	 	 /s/ Barbara Brooke Manning

	Name:	 	Barbara Brooke Manning
	Title:	 	Managing Director
	
	CLEARBRIDGE MLP AND MIDSTREAM TOTAL RETURN FUND INC.
		
	By:	 	ClearBridge Investments, LLC as
		 	discretionary manager
		
	By:	 	 /s/ Barbara Brooke Manning

	Name:	 	Barbara Brooke Manning
	Title:	 	Managing Director
	
	COHEN & STEERS MLP & ENERGY OPPORTUNITY FUND, INC.
		
	By:	 	 /s/ Tyler Rosenlicht

	Name:	 	Tyler Rosenlicht
	Title:	 	Vice President

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	COHEN & STEERS INFRASTRUCTURE
	FUND, INC.
		
	By:	 	 /s/ Benjamin Morton

	Name:	 	Benjamin Morton
	Title:	 	Vice President
	
	CUSHING MLP & INFRASTRUCTURE TOTAL RETURN FUND
		
	By:	 	Cushing Asset Management, LP,
		 	Its investment adviser
		
	By:	 	Swank Capital, LLC, its general partner
		
	By:	 	 /s/ Jerry V. Swank

	Name:	 	Jerry V. Swank
	Title:	 	Managing Member
	
	MAINSTAY CUSHING MLP PREMIER FUND
		
	By:	 	Cushing Asset Management, LP,
		 	its investment subadvisor
		
	By:	 	Swank Capital, LLC, its general partner
		
	By:	 	 /s/ Jerry V. Swank

	Name:	 	Jerry V. Swank
	Title:	 	Managing Member
	
	GOLDMAN SACHS MLP ENERGY
	INFRASTRUCTURE FUND
		
	By:	 	 /s/ Ganesh Jois

	Name:	 	Ganesh Jois
	Title:	 	Managing Director

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	GOLDMAN SACHS ENERGY
	INFRASTRUCTURE FUND
		
	By:	 	 /s/ Ganesh Jois

	Name:	 	Ganesh Jois
	Title:	 	Managing Director
	
	GOLDMAN SACHS MLP AND ENERGY
	RENAISSANCE FUND
		
	By:	 	 /s/ Ganesh Jois

	Name:	 	Ganesh Jois
	Title:	 	Managing Director
	
	Salient Midstream & MLP Fund
		
	By:	 	 /s/ Greg Reid

	Name:	 	Salient Capital Advisors, LLC
	Title:	 	Its Investment Manager
	
	Salient MLP & Energy Infrastructure Fund
		
	By:	 	 /s/ Greg Reid

	Name:	 	Salient Capital Advisors, LLC
	Title:	 	Its Investment Manager
	
	Salient MLP Total Return Fund, L.P.
		
	By:	 	 /s/ Greg Reid

	Name:	 	Salient Capital Advisors, LLC
	Title:	 	Its Investment Manager

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	Utah School & Institutional Trust Funds Office
		
	By:	 	 /s/ Ryan Kulig

	Name:	 	Ryan Kulig
	Title:	 	Officer at Utah School & Institutional Trust
		 	Funds Office
	
	TORTOISE ENERGY INFRASTRUCTURE CORP.
		
	By:	 	TORTOISE CAPITAL ADVISORS, L.L.C.
		 	as its Investment Adviser
		
	By:	 	 /s/ Brian Kessens

	Name:	 	Brian Kessens
	Title:	 	Managing Director
	
	TORTOISE MIDSTREAM ENERGY FUND, INC.
		
	By:	 	TORTOISE CAPITAL ADVISORS, L.L.C.
		 	as its Investment Adviser
		
	By:	 	 /s/ Brian Kessens

	Name:	 	Brian Kessens
	Title:	 	Managing Director
	
	TORTOISE MLP & PIPELINE FUND
		
	By:	 	TORTOISE CAPITAL ADVISORS, L.L.C.
		 	as its Investment Adviser
		
	By:	 	 /s/ Brian Kessens

	Name:	 	Brian Kessens
	Title:	 	Managing Director

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	TORTOISE ESSENTIAL ASSETS INCOME TERM FUND
		
	By:	 	TORTOISE CAPITAL ADVISORS, L.L.C.
		 	as its Investment Adviser
		
	By:	 	 /s/ Nick Holmes

	Name:	 	Nick Holmes
	Title:	 	Managing Director
	
	TORTOISE MLP & ENERGY INCOME FUND
		
	By:	 	TORTOISE CAPITAL ADVISORS, L.L.C.
		 	as its Investment Adviser
		
	By:	 	 /s/ Quinn Kiley

	Name:	 	Quinn Kiley
	Title:	 	Managing Director
	
	YAUPON FUND LP
		
	BY:	 	YAUPON CAPITAL GP LLC, ITS GENERAL PARTNER
		
	By:	 	 /s/ Steve Pattyn

	Name:	 	Steve Pattyn
	Title:	 	Managing Member

  
 Signature Page to Common
Unit Purchase Agreement 

 
			
	PARTNERSHIP:
	
	CRESTWOOD EQUITY PARTNERS LP
	
	By CRESTWOOD EQUITY GP, LLC, its general partner
		
	By:	 	 /s/ Robert T. Halpin

	Name:	 	Robert T. Halpin
	Title:	 	Executive Vice President and Chief Financial Officer

  
 Signature Page to Common
Unit Purchase Agreement 

 Schedule A – List of Purchasers and Purchased Units 

Schedule A to Common Unit Purchase Agreement 

 EXHIBIT A 

Exhibit A to Common Unit Purchase Agreement 

 EXHIBIT B 

FORM OF REGISTRATION RIGHTS AGREEMENT 

Exhibit B to Common Unit Purchase AgreementEX-4.2

 Exhibit 4.2 

SECOND AMENDED AND RESTATED SHAREHOLDERS RIGHTS AGREEMENT 

THIS SECOND AMENDED AND RESTATED SHAREHOLDERS RIGHTS AGREEMENT (this “Agreement”) is made as of this 20th day of March, 2021
by and among ironSource Ltd., an Israeli company (the “Company”), the shareholders listed on Schedule A hereto, including shareholders who have become party hereto from time to time hereafter with the consent of the Company
upon execution of the Joinder set forth in Annex A hereto and whose names will be added to an updated version of such Schedule A (the “Investors”) and the persons listed on Schedule B hereto (the
“Founders”). 
 W I T N E S S E T H: 

WHEREAS, the Company, the Investors and certain other shareholders of the Company are parties to that certain Shareholders Rights
Agreement dated November 24, 2011, as amended by Amendment No. 1 to the Shareholders Rights Agreement on January 15, 2015 and by Amendment No. 2 to the Shareholders Rights Agreement on January 13, 2016, and as amended and
restated pursuant to the Amended and Restated Shareholders Rights Agreement on November 20, 2019 (the “Prior Agreement”), and desire to amend and restate the Prior Agreement and accept the rights and covenants hereof in lieu of
their rights and covenants under the Prior Agreement; 
 WHEREAS, under that certain Agreement and Plan of Merger, dated as of
March 20, 2021 (the “Merger Agreement”), by and among the Company, Showtime Cayman, the Company’s wholly-owned subsidiary (“Merger Sub”), Showtime Cayman II, the Company’s wholly-owned subsidiary
(“Merger Sub II”), and Thoma Bravo Advantage (“TBA”), pursuant to which Merger Sub will merge with and into TBA (the “Merger”), with TBA surviving as a wholly-owned subsidiary of the Company, and
immediately thereafter TBA will merge with and into Merger Sub II, with Merger Sub II surviving such merger as a wholly owned subsidiary of the Company, and which will result in the Company’s Class A ordinary shares, no par value per
share, resulting from the recapitalization under the Merger Agreement (“Class A ordinary shares”), being registered under Section 12(b) of the 1934 Act (as defined below) and listed on the New York Stock
Exchange, and Thoma Bravo Advantage Sponsor, LLC (“TBA Sponsor”) will be issued Class A ordinary shares of the Company and, upon and subject to the closing of the Merger, will become an Investor that is a party hereto by
executing a joinder agreement, in the form attached to this Agreement as Annex A; 
 WHEREAS, the Investors, the Founders and
the Company hereby agree that this Agreement shall govern the rights of the Investors and the Founders to cause the Company to register shares issued or issuable to them and certain other matters as set forth herein; and 

WHEREAS, the Investors, the Founders and the Company desire to set forth certain other matters regarding the ownership of the shares
of the Company. 
 NOW, THEREFORE, in consideration of the mutual promises and covenants set forth herein, the parties hereby agree
to amend and restate the Prior Agreement to read in its entirety as follows: 
  

	1.	 Definitions. For purposes of this Agreement, the following terms shall have the respective
meanings provided therefor below: 

  

	 	1.1.1.	 “1934 Act” means the US Securities Exchange Act of 1934, as amended. 

 

	 	1.1.2.	 “Act” or “Securities Act” means the US Securities Act of 1933, as amended.

	 	1.1.3.	 “Business Day” means Monday through Thursday, not including holidays in Israel or in New York,
the United States. 

  

	 	1.1.4.	 “Class A ordinary shares” has the meaning provided in the Recitals hereto.

  

	 	1.1.5.	 “Class B ordinary shares” means the Company’s Class B ordinary
shares, no par value per share, that will be distributed to the Company’s existing shareholders immediately prior to the consummation of the Merger. 

  

	 	1.1.6.	 “CVC Advisory Group” means CVC Capital Partners Advisory Group Holding Foundation and each of
its subsidiaries from time to time. 

  

	 	1.1.7.	 “CVC Funds” means any investment funds or vehicles advised by one or more members of the CVC
Advisory Group. 

  

	 	1.1.8.	 “CVC Investment and Management Group” means CVC Capital Partners SICAV-FIS S.A. and each of its subsidiaries from time to time. 

  

	 	1.1.9.	 “CVC Investor” means App Investments S.à r.l., a private limited liability company
(société à responsabilité limitée) having its registered office at 20 Avenue Monterey, L-2163 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg
Trade and Companies Register (Registre de Commerce et des Sociétés) under number B 238344. 

  

	 	1.1.10.	 “CVC Investor Group” means the CVC Advisory Group, the CVC Funds or the CVC Investment and
Management Group. 

  

	 	1.1.11.	 “Form F-3” means Form
F-3 or Form S-3 under the Securities Act, as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC which permits
inclusion or incorporation of substantial information by reference to other documents filed by the Company with the SEC. 

  

	 	1.1.12.	 “Holder” means any person owning or having the right to acquire Registrable Securities or
shares convertible to Registrable Securities who acquired such Registrable Securities or shares convertible into Registrable Securities in a transaction or series of transactions not involving any registered public offering, or any assignee thereof
in accordance with Section 2.11 hereof. 

  

	 	1.1.13.	 “Initial Offering” means the Company’s first firm commitment underwritten public offering
of its Ordinary Shares registered under the Act or the equivalent law of another jurisdiction, or, alternatively, a SPAC Transaction. 

  

	 	1.1.14.	 “Initiating Holders” means either (a) Investors holding in the aggregate a majority of
the Registrable Securities and which are then held by the Investors, or (b) other Holders holding in the aggregate a majority of the Registrable Securities (assuming for purposes of such determination the conversion of all shares convertible
into Registrable Securities). 

  

	 	1.1.15.	 “Merger” has the meaning provided in the Recitals hereto. 

 

	 	1.1.16.	 “Ordinary Shares” means (i) as of the date of this Agreement, ordinary shares, par
value NIS 0.01 each, of the Company, and (ii) upon the closing of the Merger, Class A ordinary shares, including Class A ordinary shares issuable upon conversion of Class B ordinary shares, and Class B ordinary shares.

	 	1.1.17.	 “Permitted Transfer” means a transfer of Registrable Securities by any Holder that is made in
accordance with the Articles, and constitutes either (i) at least 1% of the issued and outstanding share capital of the Company on the date of transfer, or (ii) at least 50% of the Registrable Securities that are held by such Holder as of
the date hereof. 

  

	 	1.1.18.	 “register”, “registered” and “registration” refer to a
registration effected by preparing and filing a registration statement or similar document in compliance with the Act or the equivalent law of another jurisdiction, and the declaration or ordering of effectiveness of such registration statement or
document. 

  

	 	1.1.19.	 “Registrable Securities” means (i) the Ordinary Shares held by the Investors as of the
date hereof, (ii) the Ordinary Shares held by the SSA Shareholders as of the date hereof, (iii) the Ordinary Shares issued to the Founders, (iv) the Ordinary Shares issuable to TBA Sponsor pursuant to and upon consummation of the
transactions under the Merger Agreement, and (v) any Ordinary Shares of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security that is issued as) a dividend or other distribution with respect
to, or in exchange for, or in replacement of, the shares referenced in (i), (ii), (iii) or (iv) above (in all cases subject to proportional adjustment upon any stock split, reverse stock split, stock dividend, reclassification or any other
recapitalization event), excluding in all cases, however, (a) Ordinary Shares which have previously been registered under an effective registration statement filed pursuant to the Securities Act and disposed of in accordance with such
registration statement, (b) Ordinary Shares which have otherwise previously been sold to the public, (c) Ordinary Shares that could be sold by the holder thereof (in accordance with applicable law and together with any affiliates
with whom such holder must aggregate its sales under Rule 144) pursuant to Rule 144(b)(1) promulgated under the Securities Act if the holder thereof and any such affiliates hold less than five percent (5%) of the issued and outstanding
Ordinary Shares of the Company, and (d) any Registrable Securities sold in a transaction in which rights under Section 2 are not assigned in accordance with the provisions herein. The number of “Registrable Securities”
outstanding shall be determined by the number of Ordinary Shares outstanding and/or issuable pursuant to then exercisable or convertible securities, in each case that are Registrable Securities. Schedule C hereto sets forth a list of the
outstanding Registrable Securities and Holders thereof as of the date hereof. Schedule D sets forth a list of the outstanding Registrable Securities held by SSA Shareholders as of the date hereof. 

 

	 	1.1.20.	 “SEC” or “Commission” means the U.S. Securities and Exchange Commission.

  

	 	1.1.21.	 “Shareholders” means, collectively, the Founders and the Investors. Solely as and to the
extent it is used in Sections 1.13 (“Market Stand-Off” Agreement), 1.14 (Termination of Registration Rights), 2.16 (“Certain rights upon an Initial Offering”),
3.1 (“Delivery of Financial Information”), 3.8 (Confidentiality) and 5 (Miscellaneous), the term “Shareholder” shall be deemed to include the persons and entities set forth on Schedule C attached hereto (the
“SSA Shareholders”). 

	 	1.1.22.	 “SPAC Transaction” means a merger (including the Merger), consolidation, share exchange, share
purchase or other business combination between (1) the entirety of the shareholders of the Company, the Company and/or a subsidiary of the Company and (2) a publicly listed “special purpose acquisition company” (a
“SPAC”) and/or its shareholders (or a subsidiary of the publicly listed company), as a result of which either (x) the Company becomes a publicly listed Company (or a subsidiary of a publicly listed company) with Shares
registered under Section 12(b) of the 1934 Act, or (y) the shareholders of the Company immediately prior to the closing of such merger, consolidation, share exchange, share purchase or other business combination hold or have the right, by
virtue of their shareholdings in the Company, to acquire or to be issued, immediately following the closing of such merger, consolidation, share exchange, share purchase or other business combination, the majority shareholding in a publicly listed
company that is the surviving entity of such merger, consolidation, share exchange, share purchase or other business combination. 

  

	2.	 Registration Rights. 

 

	 	2.1.	 Piggyback Registration. 

 

	 	2.1.1.	 Other than in connection with a request for registration pursuant to Sections 2.2 or 2.3 of this Agreement, if
at any time the Company, including if the Company qualifies as a well-known seasoned issuer (within the meaning of Rule 405 under the Securities Act) (a “WKSI”), proposes to file (i) a prospectus supplement to an effective
shelf registration statement (a shelf registration statement, whether effective or not, a “Shelf Registration Statement”), or (ii) a registration statement (other than a Shelf Registration Statement solely for a delayed or
continuous offering pursuant to Rule 415 under the Securities Act); in either case, for the sale of Ordinary Shares for its own account, or for the benefit of the holders of any of its securities other than the Holders, to an underwriter on a firm
commitment basis for reoffering to the public or otherwise in a registered public offering (subsections (i) and (ii) collectively, a “Piggy-Back Underwritten Offering”), then as soon as practicable, but not less than fifteen
(15) Business Days prior to the filing of (a) any preliminary prospectus supplement relating to such Piggy-Back Underwritten Offering pursuant to Rule 424(b) under the Securities Act, (b) any prospectus supplement relating to such
Piggy-Back Underwritten Offering pursuant to Rule 424(b) under the Securities Act (if no preliminary prospectus supplement is used) or (c) such registration statement, as the case may be, the Company shall give notice of such proposed
Piggy-Back Underwritten Offering to the Holders (a “Piggyback Notice”) and such Piggyback Notice shall offer the Holders the opportunity to include in such Piggy-Back Underwritten Offering such number of Registrable Securities as
each such Holder may request in writing. Each such Holder shall then have ten (10) Business Days 

	 	
after receiving such Piggyback Notice to request, in written notice to the Company, the inclusion of Registrable Securities in the Piggy-Back Underwritten Offering, except that such Holder shall
have two (2) Business Days after such Holder confirms receipt of the notice to request inclusion of Registrable Securities in the Piggy-Back Underwritten Offering in the case of a “bought deal”, “registered direct offering”,
“overnight transaction” or similar offering where no preliminary prospectus is used. Upon receipt of any such request for inclusion from a Holder received within the specified time, the Company shall use reasonable best efforts to effect
the registration in any registration statement of any of the Holders’ Registrable Securities requested to be included on the terms set forth in this Agreement. Prior to the commencement of any “road show,” any Holder shall have the
right to withdraw its request for inclusion of its Registrable Securities in any registration by giving written notice to the Company of its request to withdraw and such withdrawal shall be irrevocable and, after making such withdrawal, such Holder
shall no longer have any right to include Registrable Securities in the Piggy-Back Underwritten Offering as to which such withdrawal was made. 

  

	 	2.1.2.	 (i) The Company shall give each Holder fifteen (15) Business Days’ notice prior to filing a Shelf
Registration Statement and, upon the written request of any Holder, received by the Company within ten (10) Business Days of such notice to the Holder, the Company shall include in such Shelf Registration Statement a number of Ordinary Shares
equal to the aggregate number of Registrable Securities requested to be included without naming any requesting Holder as a selling shareholder and including only a generic description of the holder of such securities (the “Undesignated
Registrable Securities”), (ii) the Company shall not be required to give notice to any Holder in connection with a filing pursuant to Section 2.1.1(i) unless such Holder provided such notice to the Company pursuant to this
Section 2.1.2 and included Undesignated Registrable Securities in the Shelf Registration Statement related to such filing, and (iii) at the written request of a Holder given to the Company more than seven (7) days before the date
specified in writing by the Company as the Company’s good faith estimate of a launch of a Piggy-Back Underwritten Offering (or such shorter period to which the Company in its sole discretion consents), the Company shall use commercially
reasonable best efforts to effect the registration of any of the Holders’ Undesignated Registrable Securities so requested to be included and shall file a post-effective amendment or, if available, a prospectus supplement to a Shelf
Registration Statement to include such Undesignated Registrable Securities as any Holder may request, provided that the Company shall not be required to effect a post-effective amendment more than four (4) times in each twelve months period.

  

	 	2.1.3.	 Right to Terminate Registration. The Company shall have the right to terminate or withdraw any
registration initiated by it under this Section 2.1 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The expenses of such withdrawn registration or offering shall
be borne by the Company in accordance with Section 2.6. 

	 	2.1.4.	 Underwriting Requirements. In connection with any Piggy-Back Underwritten Offering, the Company shall
not be required to include any of the Holders’ Registrable Securities in such offering unless such Holder accepts the terms of the underwriting as agreed upon between the Company and the underwriters selected in accordance with this
Section 2.1.4 (which terms shall be the same with respect to all Holders, except for variations resulting from jurisdiction of incorporation, tax status, corporate status and other matters relating specifically to specific Holders) and enters
into an underwriting agreement in customary form with an underwriter or underwriters selected by the Company, and then only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by
the Company. If the total amount of securities, including Registrable Securities, requested by shareholders to be included in such offering exceeds the amount of securities sold other than by the Company that the underwriters determine in their sole
discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable Securities, that the underwriters determine in their sole discretion
will not jeopardize the success of the offering (the securities so included to be apportioned among the selling Holders according to the total amount of securities entitled to be included therein owned by each such selling Holder or in such other
proportions as shall mutually be agreed to by holders of 75% in interest of such selling Holders). In all cases, the number of Registrable Securities in the offering may be reduced only if all other shareholders’ securities are first entirely
excluded from the offering. For purposes of the second sentence of this Section 2.1.4 concerning apportionment, for any selling shareholder that is a Holder of Registrable Securities and that is a partnership, limited liability company or
corporation, the partners, members, retired partners, retired members and shareholders of such Holder, or the estates and family members of any such partners, members and retired partners, retired members and any trusts for the benefit of any of the
foregoing persons shall be deemed to be a single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of Registrable Securities owned by all such related
entities and individuals. 

  

	 	2.2.	 Demand Registration. 

 

	 	2.2.1.	 Request by Holders. At any time following the closing of the Company’s Initial Offering and until
the expiration of the seventh (7th) anniversary thereof, but subject to the terms of any “lock-up agreement” entered into between the underwriters
of the Initial Offering (or, in the event that the Initial Offering is a SPAC Transaction, between the Company) and a Holder (unless waived by such underwriters), the Initiating Holders may request in writing (a “Form F-1 Request Notice”) that the Company file a registration statement under the Securities Act covering the registration of Registrable Securities pursuant to this Section 2.2.1. Within ten
(10) Business Days after receipt of any such Form F-1 Request Notice, the Company shall give written notice of such request to the other Holders and shall include in such registration all Registrable
Securities held by all such 

 Holders who wish to participate in such demand registration and provide the Company with
written requests for inclusion therein within fifteen (15) Business Days after the receipt of the Company’s notice. Thereupon, the Company shall make commercially reasonable best efforts to effect the registration under the Securities Act
of all Registrable Securities as to which it has received requests for registration; provided, however, that the Company shall not be required to effect any registration under this Section 2.2: (a) within a period of one hundred and
eighty (180) days following the effective date of a previous registration pursuant to this Section 2.2 or Section 2.3, or in which the Holders had an opportunity to participate pursuant to the provisions of Section 2.1; (b) if
the Holders propose to sell Registrable Securities at an estimated aggregate price to the public (net of any underwriters’ discounts or commissions) of less than US$5,000,000; (c) if the Company gives notice that it is engaged in preparation of
a registration statement to be filed, in the Company’s good faith estimate, within ninety (90) days from the date of the Form F-1 Request Notice in which the Holder may include its
Registrable Securities, provided that the Company is employing in good faith commercially reasonable efforts to cause such registration statement to become effective and, further provided that the Holders are entitled to request that the Company
register all of their Registrable Securities for resale pursuant to Section 2.1 of this Agreement (subject to underwriting limitations set forth in Section 2.2.2 below), provided, however, that the Company may not utilize this right
more than twice in any twelve (12) month period if, during either of the two previous usages, it did not ultimately complete a registration pursuant to which the requesting Holder was actually entitled to sell Ordinary Shares; or (d) if
such registration could be effected on a Form F-3. 
  

	 	2.2.2.	 Underwriting. 

 

	 	2.2.2.1.	 If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of
an underwriting, then they shall so advise the Company as a part of their request made pursuant to this Section 2.2 and the Company shall include such information in the written notice to the other Holders referred to above in this
Section 2.2. In such event, the right of any Holder to include its Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable
Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall enter into an underwriting agreement in customary form with the managing underwriter or underwriters
selected for such underwriting in accordance with the provisions of Section 2.13 (which underwriting agreement shall contain the same terms with respect to all such Holders, except for variations resulting from jurisdiction of incorporation,
tax status, corporate status and other matters relating specifically to specific Holders). 

	 	2.2.2.2.	 Notwithstanding any other provision of this Section 2.2, if the managing underwriter advises the Holders
in writing that marketing factors require a limitation of the number of shares to be underwritten, then there shall be excluded from such registration and underwriting to the extent necessary to satisfy such limitation, first shares held by
shareholders other than the Holders (if any), then shares which the Company may wish to register for its own account, and thereafter, to the extent necessary, shares held by the Holders (pro rata to the respective number of Registrable Securities
required by the Holders to be included in the registration); provided, however, that in any event all Registrable Securities must be included in such registration prior to any other shares of the Company. 

 

	 	2.2.3.	 General Terms. The Company shall not register securities for sale for its own account in any
registration requested pursuant to this Section 2.2 unless permitted to do so by the written consent of Holders who hold in the aggregate a majority of the Registrable Securities as to which registration has been requested. The Company may not
cause any other registration of securities for sale for its own account (other than a registration effected solely to implement an employee benefit plan) to be initiated after a registration requested pursuant to this Section 2.2 and to become
effective less than ninety (90) days after the effective date of any registration requested pursuant to this Section 2.2. 

  

	 	2.2.4.	 Maximum Number of Demand Registrations. The Company shall not be required to effect more than two
(2) registrations under this Section 2.2. 

  

	 	2.3.	 Form F-3 Registration. 

 

	 	2.3.1.	 Form F-3 Requests. In case the Company shall receive from any
Holder or Holders a written request or requests (a “Form F-3 Request Notice”) that the Company effects a registration on Form F-3, and any related
qualification or compliance, with respect to Registrable Securities, then, subject to the conditions of this Section 2.3, the Company will give written notice of the proposed registration within fifteen (15) Business Days after receipt of
any such Form F-3 Request Notice to all other Holders, and include in such registration all Registrable Securities held by all such Holders who wish to participate in such registration and who have provided
the Company with written notice requests for inclusion therein within ten (10) Business Days after the receipt of the Company’s notice. As soon as practicable, and in any event within sixty (60) Business Days after the receipt of any
such Form F-3 Request Notice, the Company shall file such Form F-3 registration statement under the Securities Act. The Company shall not be obligated to make any filing
of a Form F-3 pursuant to this Section 2.3 if the Company has, within a ninety (90) day period preceding the date of such request, already effected a registration under the Securities Act pursuant to
Section 2.2 or this Section 2.3, or in which the Holders had an opportunity to participate pursuant to the provisions of Section 2.1. All written requests from any Holder or Holders to effect a registration on 

 Form F-3 pursuant to this Section 2.3 shall
indicate whether such Holder(s) intend to effect the offering promptly following effectiveness of the registration statement or whether, pursuant to Section 1.4, they intend for the registration statement to remain effective so that they may
effect the offering on a delayed basis (a “Shelf Request”). 
  

	 	2.3.2.	 Shelf Request. In the event that a Form F-3 is filed pursuant to
a Shelf Request, upon a written request (a “Form F-3 Demand Notice”) from any Holder or Holders that is entitled to sell securities pursuant to such Form
F-3 without filing a post-effective amendment that the Company effect an offering with respect to Registrable Securities (a “Takedown”), the Company will, as soon as practicable,
(a) deliver a notice relating to the proposed Takedown to all other Holders who are named or are entitled to be named as a selling shareholder in such Form F-3 without filing a post-effective amendment
thereto and (b) promptly (and in any event not later than twenty (20) Business Days after receiving such request) supplement the prospectus included in the Shelf Registration Statement as would permit or facilitate the sale and
distribution of all or such portion of the Holders’ Registrable Securities as are specified in such request, together with the Registrable Securities requested to be included in such Takedown by any Holders who notify the Company in writing
within ten (10) Business Days after receipt of such notice from the Company; except that (i) the Registrable Securities requested to be offered pursuant to such Takedown must have an anticipated aggregate price to the public (net of any
underwriting discounts and commissions) of not less than US$1,000,000, and (ii) the Company shall not be obligated to effect any such Takedown (x) if the Company has within the twelve (12) month period preceding the date of such
request already effected four (4) Takedowns under this Section 2.3 pursuant to which the requesting Holder was actually entitled to sell Ordinary Shares or (y) within ninety (90) days of effecting a previous Takedown under this
Section 2.3 or an offering pursuant to Section 2.2. 

  

	 	2.3.3.	 Registration. The Company shall not be obligated to effect any such registration, qualification or
compliance, pursuant to this Section 2.3: 

 (i) if
Form F-3 is not available for such offering by the Holders; 
 (ii) if the
Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an estimated aggregate price to the public (net of any
underwriters’ discounts or commissions) of less than US$1,000,000; or 
 (iii) if the Company gives notice that it is
engaged in preparation of a registration statement to be filed within ninety (90) days in which the Holder may include its Registrable Securities, provided that the Company is employing in good faith commercially reasonable efforts to cause
such registration statement to become effective and, further provided that the Holders are entitled to request that the Company register all of their Registrable Securities for resale pursuant to Section 2.12.1 of this Agreement (subject to
underwriting limitations), provided, however, that the Company may not utilize this right more than twice in any twelve (12) month period if, during either of the two previous usages, it did not ultimately complete a registration pursuant to
which the requesting Holder was actually entitled to sell Ordinary Shares. 

	 	2.3.4.	 Not Demand Registration. Form F-3 registrations shall not be
deemed to be demand registrations as described in Section 2.2 above. 

  

	 	2.4.	 Obligations of the Company. Whenever required under this Section 2 to effect the registration of
any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

  

	 	2.4.1.	 prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its
commercially reasonable efforts to cause such registration statement to become effective, and, upon the request of (a) the Investors holding in the aggregate a majority of the Registrable Securities which were acquired on or prior to the
closing of the Purchase Agreement or at the Deferred Closing thereof by the Investors and which are then held by the Investors and registered thereunder or (b) other Holders holding in the aggregate a majority of the Registrable Securities
registered thereunder, keep such registration statement effective for a period of up to one hundred and eighty (180) days, or, if earlier, until the distribution contemplated in the registration statement has been completed;

  

	 	2.4.2.	 prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus
used in connection with such registration statement as may be necessary to comply with the provisions of the Act with respect to the disposition of all securities covered by such registration statement; 

 

	 	2.4.3.	 furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in
conformity with the requirements of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

 

	 	2.4.4.	 use its commercially reasonable efforts to register and qualify the securities covered by such registration
statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business
or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdictions and except as may be required under the Act; 

 

	 	2.4.5.	 in the event of any underwritten public offering, enter into and perform its obligations under an underwriting
agreement, in usual and customary form, with the managing underwriter of such offering; 

  

	 	2.4.6.	 notify each Holder of Registrable Securities covered by such registration statement at any time when a
prospectus relating thereto is required to be delivered under the Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing; 

	 	2.4.7.	 cause all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange on
which similar securities issued by the Company are then listed; 

  

	 	2.4.8.	 provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP
number for all such Registrable Securities, in each case not later than the effective date of such registration; 

  

	 	2.4.9.	 cause senior representatives of the Company to participate in any “road show” or “road
shows” reasonably requested by any underwriter of an underwritten or “best efforts” offering of Registrable Securities; and 

  

	 	2.4.10.	 subject to each selling Holder to whom the comfort letter is addressed providing a customary representation
letter to the independent registered public accounting firm of the Company in form and substance reasonably satisfactory to such accountants, (A) use its commercially reasonable best efforts to obtain customary “comfort” letters from
such accountants (to the extent deliverable in accordance with their professional standards) addressed to such selling Holder (to the extent consistent with the Statement on Auditing Standards No. 100 of the American Institute of Certified
Public Accountants) and the managing underwriter(s), if any, in customary form and covering matters of the type customarily covered in “comfort” letters in connection with underwritten offerings and (B) use its commercially reasonable
best efforts to obtain opinions of counsel to the Company and updates thereof covering matters customarily covered in opinions of counsel in connection with underwritten offerings, addressed to each selling Holder and the managing underwriter(s), if
any, provided that the delivery of any “10b-5 statement” and opinion may be conditioned on the prior or concurrent delivery of a comfort letter pursuant to subsection (A) above; provided,
further that the Company shall only be required to comply with this Section 1.5.10 in connection with an underwritten offering. 

  

	 	2.5.	 Information from Holders. It shall be a condition precedent to the obligations of the Company to take
any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended
method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. 

  

	 	2.6.	 Expenses of Registration. All expenses other than underwriting discounts and commissions incurred in
connection with registrations, filings or qualifications pursuant to Sections 2.1, 2.2 and 2.3 including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel
for the Company and the reasonable fees and disbursements of one U.S. counsel for all selling Holders shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration
proceeding begun pursuant to Sections 2.2 or 2.3 if the registration request is subsequently withdrawn at the request of the Holders of more than fifty percent (50%) of the Registrable Securities to be registered or included in an offering

 pursuant to a Shelf Request (in which case all Holders who participated in marking such
requests to withdraw shall bear such expenses pro rata based upon the number of Registrable Securities that were to be included in the withdrawn registration) unless, in the case of Section 2.2, such Holders agree that such registration
constitutes the use by the Holders of one (1) demand registration under Section 2.2.4; provided further, however, that if any such withdrawal is based upon information showing a material adverse change in the condition, business, or
prospects of the Company and was not known or available to such Holders at the time of their request for such registration, and such Holders have withdrawn their request for registration with reasonable promptness after learning of such material
adverse change, the Holders shall not be required to pay any of such expenses and such registration shall not constitute the use of a demand registration under Section 2.2.4. 

 

	 	2.7.	 Deferral and Suspension. Notwithstanding any other provision of this Section 2, if the Company
shall furnish to Holders requesting the filing of a registration statement or the initiation of an offering a certificate signed by the Chairman of the Board of Directors of the Company (the “Board”) stating that in the good faith
judgment of the Board, it would be materially detrimental to the Company and its shareholders for such registration statement to be filed or offering to be undertaken, for instance, if it would (i) materially interfere with a significant
acquisition, corporate reorganization, or other similar transaction involving the Company, (ii) require premature disclosure of material information that the Company has a bona fide business purpose for preserving as confidential or
(iii) render the Company unable to comply with requirements under applicable securities laws, then the Company shall have the right to defer the filing of a registration statement or suspend the use of a registration statement; provided,
however, that the Company may not utilize this right more than twice in any twelve (12) month period and not for more than ninety (90) days for each such deferral or suspension. 

 

	 	2.8.	 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining or
otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

 

	 	2.9.	 Indemnification. In the event any Registrable Securities are included in a registration statement under
this Section 2: 

  

	 	2.9.1.	 To the extent permitted by law, the Company will indemnify and hold harmless each selling Holder, the partners,
members or officers, directors and shareholders of each Holder, legal counsel and accountants for each selling Holder, any underwriter (as defined in the Act) for such Holder, any Holder deemed to be an underwriter (as determined under the
Securities Act) and each person, if any, who controls such Holder or underwriter within the meaning of the Act or the 1934 Act (a “Holder Indemnitee”), against any losses, claims, damages or liabilities (joint or several) to
which they may become subject under the Act, the 1934 Act, the securities laws of Israel, any state securities laws or any rule or regulation promulgated under the Act or any such other law, insofar as such losses, claims, damages, or liabilities
(or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (collectively a “Violation”): (i) any untrue statement or alleged untrue statement of a material fact
contained in such registration statement, 

 including any preliminary prospectus or final prospectus contained therein or any
amendments or supplements thereto or any disclosure package filed with the SEC, (ii) the omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or
(iii) any violation or alleged violation by the Company of the Act, the 1934 Act, the securities laws of Israel, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act, the securities laws of Israel or any
state securities laws; and the Company will reimburse each such Holder Indemnitee promptly upon demand for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability
or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 2.9.1 shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is
effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any such case to a Holder Indemnitee for any such loss, claim, damage, liability or action to the extent that it
arises out of or is based upon a Violation that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such registration statement by such Holder Indemnitee. 

 

	 	2.9.2.	 To the extent permitted by law, each selling Holder will severally and not jointly indemnify and hold harmless
the Company, each of its directors and each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, legal counsel and accountants for the Company, any underwriter, any
other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages or liabilities (joint or several) to which any of the foregoing persons may become
subject, under the Act, the 1934 Act, the securities laws of Israel, any state securities laws or any rule or regulation promulgated under the Act, the 1934 Act, the securities laws of Israel or any state securities laws, insofar as such losses,
claims, damages or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information
furnished by such Holder expressly for use in connection with such registration statement; and each such Holder will reimburse any person intended to be indemnified pursuant to this subsection 2.9.2, for any legal or other expenses reasonably
incurred by such person in connection with investigating or defending any such loss, claim, damage, liability or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 2.9.2 shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent of the Holder (which consent shall not be unreasonably withheld), provided that in no event shall any
indemnity under this subsection 2.9.2 exceed the gross proceeds from the offering (less underwriter’s commissions and discounts) received by such Holder. 

	 	2.9.3.	 Promptly after receipt by an indemnified party under this Section 2.9 of notice of the commencement of any
action (including any governmental action) involving the subject matter of the foregoing indemnity provisions, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without conflict by one counsel)
shall have the right to retain one separate counsel, with the reasonable fees and expenses thereof to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the indemnifying party within a reasonable time
of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.9 to the extent of such prejudice, but the
omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 2.9. No indemnifying party will consent to entry of any judgment or
enter into any settlement which does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect to such claim or litigation. 

 

	 	2.9.4.	 If the indemnification provided for in this Section 2.9 is held by a court of competent jurisdiction to be
unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall, subject to the limitation set forth
in this Section 2.9.4, contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party
on the one hand and of the indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense, as well as any other relevant equitable considerations. Notwithstanding
anything to the contrary contained herein, in no event shall the contribution obligation of any Holder set forth in this Section 1.10.4 exceed the gross proceeds from the offering received by such Holder (less underwriter’s commissions and
discounts when combined with any amounts paid by such Holder pursuant to Section 2.9.2), and in no event shall the contribution obligation of any Holder exceed the amount that such Holder would have been required to pay as indemnification if
indemnification had been applicable in accordance with the above terms of this Section 2.9. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, 

 among other things, whether the untrue or alleged untrue statement of a material fact or
the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or
prevent such statement or omission. 
  

	 	2.9.5.	 Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained
in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

 

	 	2.9.6.	 The obligations of the Company and Holders under this Section 2.9 shall survive the completion of any
offering of Registrable Securities in a registration statement under this Section 2, and otherwise. 

  

	 	2.10.	 Reports Under Securities Exchange Act of 1934. With a view to making available to the Holders the
benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form F-3, the Company agrees to: 

  

	 	2.10.1.	 make and keep public information available, as those terms are understood and defined in Rule 144
promulgated under the Act, at all times after the effective date of the Initial Offering; 

  

	 	2.10.2.	 file with the SEC in a timely manner all reports and other documents required of the Company under the Act and
the 1934 Act; and 

  

	 	2.10.3.	 furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a
written statement by the Company that it has complied with the reporting requirements of Rule 144 promulgated under the Act (at any time after ninety (90) days after the effective date of the first registration statement filed by the
Company), the Act and the 1934 Act (at any time after it has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form F-3 (at any
time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the SEC, and (iii) such other information as may be reasonably
requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant to such form. 

 

	 	2.11.	 Assignment of Registration Rights. Any Holder that transfers Registrable Securities pursuant to a
Permitted Transfer may assign to the respective transferee, together with such transfer, its rights to cause the Company to register such Registrable Securities pursuant to Section 2 hereof (but together with and subject to all obligations of
such Holder under Section 1). The transferor shall, as a condition to such transfer, furnish the Company with written notice of the name and address of such transferee and the Registrable Securities with respect to which such registration
rights are being assigned, and the transferee’s written agreement to be bound by the transferee’s obligations hereunder. 

	 	2.12.	 “Market Stand-Off” Agreement.
Each Shareholder (for purposes of this Section 2.12, the “Lock-up Shareholder”), hereby agrees that it will not, without the prior written consent of the managing underwriter of the
Company (or, in the case of an Initial Offering that is a SPAC Transaction, the prior written consent of the Company), during the period commencing on the date of the final prospectus relating to any underwritten offering of the Company, or in the
case of an Initial Offering that is a SPAC Transaction, the date of the consummation of the SPAC Transaction (including any offering referred to in Section 2.2 (Demand Registration)) and ending on the date specified by the Company and, if
applicable, the managing underwriter (such period not to exceed (a) one hundred and eighty (180) days in connection with the Initial Offering and (b) ninety (90) days in connection with any other offering, as is required by
(x) the underwriter in case of any offering or (y) by the Company in case of a SPAC Transaction) (i) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant
any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, Ordinary Shares, or any securities convertible into or exercisable or exchangeable for Ordinary Shares held by such
Lock-up Shareholder prior to the Company’s Initial Offering or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of
ownership of any such shares, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Ordinary Shares or other securities of the Company, in cash or otherwise (the “Lock-Up”). The foregoing provisions of this Section 1.13 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable if all officers
and directors and greater than one percent (1%) shareholders of the Company enter into or are bound by similar agreements. Any waiver provided to any Lock-Up Shareholder by the Company or the underwriters with
respect to the obligations set forth in this Section 2.12 shall apply to the other Lock-Up Shareholders on a proportional basis. The underwriters are intended third party beneficiaries of this
Section 2.12 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. In addition, at the underwriters’ request (or, in the case of an Initial Offering that is a SPAC Transaction,
the Company’s request), each Lock-up Shareholder shall enter into a lock-up agreement in a form customarily used by such underwriter (or by the Company) reflecting
the foregoing. The obligations described in this Section 2.12 shall not apply to a registration relating solely to employee benefit plans on Form S-8 or similar forms that may be promulgated in the
future, or a registration relating solely to a Commission Rule 145 transaction on Form F-4 or similar forms that may be promulgated in the future (other than a SPAC Transaction, to which these obligations will
apply). The Company may impose stop-transfer instructions with respect to the Ordinary Shares (or other securities) subject to the foregoing restriction until the end of said one hundred and eighty (180) day or ninety (90) day period.
In addition to the foregoing, no Holder that would be required to sign an agreement restricting its ability to transfer pursuant to this Section 1.13 shall distribute shares to its shareholders, partners or members after receipt of a
Piggyback Notice or a Form F-1 Request Notice until such time as such Holder has signed such an agreement required pursuant hereto. 

 In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period.
Notwithstanding the foregoing, if (i) during the last seventeen (17) days of the one hundred eighty (180)-day restricted period, the Company issues an earnings release or material news or a material
event relating to the Company occurs; or (ii) prior to the expiration of the one hundred eighty (180)-day restricted period, the Company announces that it will release earnings results during the sixteen (16)-day period beginning on the last day of the one hundred eighty (180)-day period, the restrictions imposed by this Section 1.13 shall continue to apply until the
expiration of the eighteen (18)-day period beginning on the issuance of the earnings release or the occurrence of the material news or material event. 

To the extent that there shall be discretionary releases of shares from the Lock-Up, such discretionary
releases of shares shall be allocated to all Holders that are subject to the Lock-Up on a pro rata basis based on the number of shares of Ordinary Shares held by the Holders that are subject to the Lock-Up. 
  

	 	2.13.	 Termination of Registration Rights. No shareholder shall be entitled to exercise any rights under
Section 2 after the date that is seven (7) years after the date of the Initial Offering. 

  

	 	2.14.	 Designation of Underwriter. In the case of any registration effected pursuant to Sections 2.2 and
2.3 of this Agreement, the Initiating Holders that submitted the request for registration shall have the right to designate the managing underwriter(s) in any underwritten offering, with the consent of the Company (not to be unreasonably
withheld), at the Company’s expense. With respect to a Piggy-Back Underwritten Offering effected under Section 2.1, the Company shall designate the managing underwriter(s). 

 

	 	2.15.	 Initiation of an IPO. To the extent an Initial Offering is initiated by the Company’s Board of
Directors, each Shareholder shall reasonably support such Initial Offering. Following the third anniversary of the original date of the Prior Agreement, the holders of the majority of the Investor Shares (as such term is defined in the
Company’s Articles of Association, as may be amended from time to time), may require the Company, by written notice thereto, to initiate an IPO process, however, the parties are aware that any IPO process may not necessarily be consummated
successfully (e.g., due to market circumstances, advice of underwriters and other reasons). The rights under the previous sentence shall terminate upon consummation of an Initial Offering (including a SPAC Transaction). 

 

	 	2.16.	 Certain rights upon an Initial Offering. In the event an Initial Offering is consummated, the
Shareholders shall use their voting right as shareholders, to ensure that the CVC Investor will have at least one Board seat immediately following the Initial Offering, provided that as of immediately prior to the Initial Offering CVC holds at least
15% of the issued and outstanding share capital of the Company. 

  

	3.	 Covenants of the Company. 

 

	 	3.1.	 Delivery of Financial Statements. The Company shall deliver to each Investor and to each of the
Founders: 

  

	 	3.1.1.	 as soon as practicable, but in any event within ninety (90) days after the end of each fiscal year of the
Company, an income statement for such fiscal year, a balance sheet of the Company and statement of shareholder’s equity as of the end of such year, and a statement of cash flows for such year, such
year-end financial reports to be in reasonable detail and United States 

 dollar-denominated, on a consolidated basis, prepared in accordance with United States
generally accepted accounting principles (“GAAP”), and audited and certified by one of the “Big Four” firms of Independent Certified Public Accountants with offices in the State of Israel who are members of the Israeli
Institute of Certified Public Accountants (the “Auditors”), and accompanied by an opinion of such accounting firm which opinion shall state that such balance sheet and income statement and statement of cash flow have been prepared
in accordance with GAAP applied on a basis consistent with that of the preceding fiscal year, and present fairly in all material respects the financial position of the Company as of their date, and that the audit by the Auditors in connection with
such financial statements has been made in accordance with GAAP; 
  

	 	3.1.2.	 as soon as practicable, but in any event within sixty (60) days after the end of each of the first three
quarters of each fiscal year of the Company, an unaudited, consolidated income statement, statement of cash flows for such fiscal quarter and an unaudited balance sheet as of the end of such fiscal quarter, and in the case of the first, second and
third quarterly periods, for the period from the beginning of the current fiscal year to the end of such quarterly period, setting forth in each case in comparative form the figures for the corresponding period of the previous fiscal year, all in
reasonable detail and United States dollar-denominated, prepared in accordance with GAAP applied on a basis consistent with that of preceding periods subject to (a) there being no footnotes contained therein and (b) changes resulting from year-end audit adjustments, and all reviewed by the Auditors; and 

  

	 	3.1.3.	 such other information relating to the financial condition, business, prospects or corporate affairs of the
Company as an Investor or a Founder may from time to time reasonably request. 

  

	 	3.2.	 Inspection. The Company shall permit each Investor and/or any of the Founders, at each such party’s
own expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by the
Investor and/or the Founders, for any purpose whatsoever. In addition, but subject to the foregoing, the Company will deliver to any Investor and/or Founder with reasonable promptness, such information and data with respect to the Company, as such
Investor and/or Founder may from time to time reasonably request. This Section 2.2 shall not be in limitation of any rights which an Investor or the directors designated by such Investor may have under applicable law. 

 

	 	3.3.	 Accounting. The Company will maintain and cause each of its Subsidiaries (if any) to maintain a system
of accounting established and administered in accordance with GAAP consistently applied, and will set aside on its books and cause each of its operating Subsidiaries to set aside on its books all such proper reserves as shall be required by GAAP.
For purposes of this Agreement, “Subsidiary” means any corporation or entity at least a majority of whose voting securities are at the time owned by the Company, or by one or more Subsidiaries, or by the Company and one or more
Subsidiaries. 

	 	3.4.	 Insurance. The Company has obtained from financially sound and reputable insurers and until the
consummation of an Initial Offering shall pay all premiums and maintain in full force and effect, directors’ and officers’ liability insurance in a form and coverage satisfactory to the Board, for an amount of at least Three Million United
States Dollars (US$3,000,000). 

  

	 	3.5.	 Proprietary Information and Non-Competition Agreements. The
Company, its wholly owned and controlled subsidiaries will not employ, or continue to employ or otherwise engage the services of, any person whether or not such person has or will have access to confidential information with respect to the Company
and such subsidiaries and their respective operations, unless such person has executed and delivered a Proprietary Information and Non-Competition Agreement in a form approved by the Company’s management
from time to time. For the sake of clarification, this Section 3.5 shall not apply to any non-executive members of the Board. 

 

	 	3.6.	 Annual Plan. The management of the Company shall establish annually an operating plan and budget for the
Company (the “Annual Plan”), in consultation with the Board. The Annual Plan for the following year shall be submitted to the Board for its approval at least thirty (30) days prior to the first day of the year covered by such
Annual Plan. 

  

	 	3.7.	 Termination of Information and Inspection Covenants. The covenants of the Company and the rights of each
of the Investors and the Founders set forth in Sections 3.1 through 3.6 as well as Section 4 shall terminate and be of no further force or effect with respect to any Investor or Founder (as the case may be), upon the earlier to occur of
(a) such Investor or Founder, as applicable, ceasing to hold more than 0.4% of the issued and outstanding share capital of the Company, (b) the consummation of a Deemed Liquidation Event (as defined in the Articles of Association of the
Company, as may be amended from time to time (the “Articles”)), and (c) upon the consummation by the Company of an Initial Offering (including a SPAC Transaction) or when the Company first otherwise becomes subject to the
periodic reporting requirements of Sections 12(g) or 15(d) of the 1934 Act, whichever event shall first occur. The Company may refrain from providing any of the information pursuant to Section 3 and Section 4 if and to
the extent the Board (acting reasonably and in good faith) determines that (i) such information involves personal information (unless the personal information can be redacted or removed); (ii) the disclosure of such information would be
reasonably expected to adversely affect the attorney-client privilege between the Company and its counsel; or (iii) the disclosure of such information would be reasonably expected to create a conflict of interests or potential conflict of
interests between the Company and the recipient of such information or any of its Affiliates, unless in case of the CVC Investor, in each case of (i) and (iii), to the extent that the CVC Investor Group is required to receive such information
pursuant to mandatory law or bona fide fund regulation and the disclosure thereof does not constitute a violation of law by the Company. 

  

	 	3.8.	 Confidentiality. Each Shareholder (without derogating from any other agreement such Shareholder may have
with the Company or any obligation under applicable law) undertakes to keep confidential and not disclose, divulge, or use for any purpose (other than to monitor its holdings in the Company) any confidential information obtained from the Company or
its subsidiaries pursuant to the terms of this Agreement or otherwise (including notice of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes 

 known to the public in general (other than as a result of a breach of this Agreement or
other confidentiality obligation by such Shareholder), (b) is or has been made known or disclosed to such party by a third party without, to such party’s knowledge, a breach of any obligation of confidentiality such third party may have to the
Company or its subsidiaries, or (c) was in such party’s possession or known by such party without restriction or confidentiality obligation prior to receipt from the Company as evidenced by written records; provided, however, that a
Shareholder may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its investment in the Company or the
enforcement of any of its rights as a shareholder of the Company and provided that such persons are bound by confidentiality obligations no less onerous than the terms hereof and further provided that such Shareholder remains responsible towards the
Company for any unauthorized disclosure by such persons; (ii) to any prospective purchaser of any Registrable Securities from such Shareholder, if such prospective purchaser agrees in advance and in writing to keep such information confidential
and to be bound by confidentiality undertakings towards the Company in a form acceptable to the Company, provided that if such prospective purchaser is not a purely financial investor (including, if it is a competitor of the Company, as shall be
determined in good faith by the Board), such disclosure shall require the Company’s prior consent; (iii) if such Shareholder is an Investor, the Investor may make a general disclosure, not containing proprietary information or intellectual
property or other highly confidential non-financial matters, regarding the general nature of the Company including its financial condition (including summary and general information regarding the
Company’s revenues and profits) to its shareholders, equityholders, partners or members in connection with periodic reports thereto; (iv) with regard to the CVC Investor to any entity within the CVC Investor Group) and each of their
respective directors, officers, consultants, advisors or employees purely on a need to know basis (each of the foregoing persons under (i) through (iv), a “Permitted Disclosee”); provided that such Permitted Disclosees are
under an obligation to keep such information confidential and such Investor remains responsible towards the Company for any breach by such Permitted Disclosees; and (v) as otherwise required by applicable law, provided that the Shareholder
notifies the Company in advance of such disclosure and takes reasonable steps, at the Company’s request and expense, to minimize the extent of any such required disclosure, subject to applicable law. Furthermore, nothing contained herein shall
prevent any party hereto from entering into any business, entering into any agreement with a third party, or investing in or engaging in investment discussions with any other company (whether or not competitive with the Company), provided
that such party does not, except as permitted in accordance with this Section 3.8, disclose or otherwise make use of any proprietary or confidential information of the Company in connection with such activities. 

 

	4.	 [Reserved] 

  

	5.	 Miscellaneous. 

 

	 	5.1.	 Successors and Assigns. Except as otherwise expressly set forth herein or pursuant to a Permitted
Transfer, none of the rights, privileges, or obligations set forth in, arising under, or created by this Agreement may be assigned or transferred without the prior consent in writing of the other parties to this Agreement. Subject to the foregoing,
the provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto. 

	 	5.2.	 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and
are not to be considered in construing or interpreting this Agreement. 

  

	 	5.3.	 Notices. Any notice required or permitted by any provision of this Agreement shall be given in writing
and shall be delivered personally, by courier, by registered or certified mail, postage prepaid, by facsimile or by e-mail, addressed (i) in the case of the Company, to its principal office; (ii) in
the case of any Shareholder which is a party to this Agreement from time to time, at the address of such Shareholder as set forth in the records of the Company or such other address for such Shareholder as shall be designated in writing from time to
time by such Shareholder. Notices shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) upon electronic confirmation of transmission, when sent by facsimile or
e-mail, or if sent during a non-Business Day, then on the first Business Day following electronic confirmation of transmission, (iii) five (5) Business Days after
having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of
receipt. Any notice of change of address shall only be valid upon receipt. 

  

	 	5.4.	 [Reserved] 

  

	 	5.5.	 Entire Agreement; Amendments and Waivers. This Agreement (including the Schedules and Exhibits hereto,
if any) amends and restates the Prior Agreement in its entirety and constitutes the full and entire understanding and agreement among the parties with regard to the subjects hereof and thereof. Any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the holders of a majority of the Registrable
Securities; provided that (a) in the event that such amendment or waiver affects the obligations or rights of any Investor or group of Investors in an adverse and disproportionate manner when compared to other Shareholders or Investors,
such amendment or waiver shall also require the written consent of the Investors holding in the aggregate a majority of the Registrable Securities then held by the Investors and affected by such amendment or waiver (considered as a single class),
and (b) any amendment (A) to sub-section (a) of Section 1.1.17 (Initiating Holders), (B) to subsection (i) of Section 1.1.21 (Registrable Securities), (C) to subsections
(a) and (b) of this Section 3.5, (D) to Sections 3.1 (Delivery of Financial Statements), 3.2 (Inspection) or 3.7 (Termination of Information and Inspection Covenants), (E) which otherwise substantially defeats the rights granted to the
Investors under Sections 2.1 (Piggyback Registration), 2.2 (Demand Registration), 2.6 (Expenses of Registration), or 2.11 (Assignment of Registration Rights), 2.12 (Market Stand Off) 2.13 (Termination of Registration Rights) (but not any other
amendments to these sections that do not substantially defeat the rights granted thereunder to the Investors), shall also require the approval of Investors holding in the aggregate a majority of the Registrable Securities then held by the Investors
(considered as a single class). Any amendment or waiver effected in accordance with this Section shall be binding upon the parties and their respective future transferees. 

	 	5.6.	 Severability. If one or more provisions of this Agreement or the application of any such provision to
any person or set of circumstances, are held to be unenforceable, unlawful or invalid under applicable law, such provision shall be excluded from this Agreement and the remaining provisions of the Agreement and the application of such provisions to
persons or circumstances other than those as to which it is determined to be unenforceable unlawful or invalid shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 

 

	 	5.7.	 Aggregation of Shares. All shares of Registrable Securities held or acquired by a Shareholder and its
Permitted Transferee (as such term is defined in the Articles) shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

 

	 	5.8.	 Termination. Without limitation of any other provision hereof, this Agreement ceases to apply to a
Shareholders as soon as the Shareholder ceases to hold any Registrable Securities, provided that the covenants and rights under Section 3 shall terminate in accordance with Section 3.7 and Section 3.8 shall continue to apply to any
confidential information referred to in Section 3.8. 

  

	 	5.9.	 Construction. Each of the parties acknowledges that it had assessed the risk,
uncertainties and benefits of this Agreement, the documents referred to herein to which it is a party and the transactions contemplated hereunder and thereunder, and that it was represented by legal counsel in the negotiation, execution and delivery
of such documents. Accordingly, and based on the foregoing facts, among other factors, each party acknowledges and agrees that, for purposes of interpreting this Agreement or any other document referred to herein to which it is a party, no party has
had any preference in the design of the provisions of this Agreement (within the meaning of Section 25(b1) of the Contracts Law (General Part), 1973 (as amended)). 

 

	 	5.10.	 Governing Law; Jurisdiction. This Agreement shall be governed by and construed under the laws of the
State of Israel without regard to its choice of law rules. The competent courts located in Tel Aviv-Jaffa shall have exclusive jurisdiction over any dispute arising in connection with or as a result of this Agreement and each of the parties hereto
expressly and irrevocably consents and submits to the exclusive jurisdiction of such courts, and agrees that process may be served upon them in any manner authorized by the laws of the State of Israel for such persons and waives and covenants not to
assert or plead any objection which they might otherwise have to such jurisdiction, venue and such process. 

  

	 	5.11.	 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed
an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have
been duly and validly delivered and be valid and effective for all purposes. 

 [Signature Pages Follow] 

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Shareholders Rights
Agreement as of the date first above written. 
  

			
	COMPANY:
	
	IRONSOURCE LTD.
		
	By:	 	 /s/ Tomer Bar Zeev

	Name:	 	Tomer Bar Zeev
	Title:	 	CEO
		
	By:	 	 /s/ Assaf Ben Ami

	Name:	 	Assaf Ben Ami
	Title:	 	CFO

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Shareholders Rights
Agreement as of the date first above written. 
  

			
	        INVESTOR:
	
	        APP INVESTMENTS S.À R.L.
		
	By:	 	 /s/ Carmen André

	Name:	 	Carmen André
	Title:	 	Director
	
	Address: ##  ######  ######
	
	#-####  ##########

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Shareholders Rights
Agreement as of the date first above written. 
  

			
	        INVESTOR:
	
	        VIOLA VENTURES III, L.P.
		
	By:	 	 /s/ Shlomo Dovrat

	Name:	 	Shlomo Dovrat
	Title:	 	General Partner
		
	By:	 	 /s/ Itzik Avidor

	Name:	 	Itzik Avidor
	Title:	 	CFO & Partner
	
	Address:

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Shareholders Rights Agreement as of
the date first above written. 
 INVESTOR: 

Solely with respect to Sections 2 (Registration Rights), Section 3.8 (Confidentiality) and 3 (Miscellaneous) of this Agreement (and, for the avoidance of
doubt, not for any other section of the Agreement), the SSA Shareholders shall be deemed parties to this Agreement. Accordingly, the signatures of the SSA Shareholders are affixed hereto for such purposes only: 

 

			
	        [NAME OF SSA SHAREHOLDER]
		
	By:	 	
                     
                                        

	Name:	 	
	Title:	 	
	
	Address:

 IN WITNESS WHEREOF, the parties have executed this Amended and Restated Shareholders Rights
Agreement as of the date first above written. 
  

	
	
	FOUNDERS:
	
	 /s/ Tomer Bar Zeev

	TOMER BAR ZEEV
	
	 /s/ Eyal Milrad

	EYAL MILRAD
	
	 /s/ Itay Milrad

	ITAY MILRAD
	
	 /s/ Roi Milrad

	ROI MILRAD
	
	 /s/ Tamir Carmi

	TAMIR CARMI
	
	 /s/ Arnon Harish

	ARNON HARISH
	
	 /s/ Nethanel Shadmi

	NETHANEL SHADMI

 ANNEX A 

Form of Joinder Agreement to 

SECOND AMENDED AND RESTATED SHAREHOLDERS RIGHTS AGREEMENT 

of 
 IRONSOURCE LTD. 

This Joinder Agreement (this “Joinder”) is executed and delivered as of [    *    ] in respect of
that certain Second Amended and Restated Shareholders Rights Agreement, dated as of March [*], 2021 by and among ironSource Ltd., an Israeli company (the “Company”), the Company’s shareholders listed on Schedule A
thereto (the “Investors”) and the Company’s Founders listed on Schedule B thereto (the “SRA”). Capitalized terms used but not defined herein shall have the meaning ascribed to them in the SRA.

 By executing and delivering this Joinder with the Company, the undersigned hereby joins and becomes a party to the SRA with all of the rights and subject
to all of the obligations of an “Investor” under the SRA, and shall be added to Schedule A thereto and shall be considered an “Investor” for all purposes of the SRA. 

IN WITNESS WHEREOF the parties have signed this Agreement as of the date first hereinabove set forth. 

 

			
	By:	 	
                     
                                         
               

	Name of Investor:
                                         
               
	If Investor is an entity, title of Investor:                
	
	ACCEPTED AND ACKNOWLEDGED:
	
	ironSource Ltd.
		
	By:	 	
                     
                                         
                   

	Name:	 	
	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]